今日の心臓手術の適応と至適時期

出版社： 文光堂
著者：
発行日： 2011-09-19
分野： 臨床医学：外科  >  心臓/血管外科
ISBN： 9784830619083
電子書籍版： 2011-09-19 （第1版第4刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

16,500 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

心臓手術の適応とその至適時期の決定についてのスタンダードを，内科，外科，先天性心疾患については小児科も交えて解説。

目次

  • 今日の心臓手術の適応と至適時期

    ―目次―

    総説
    　内科医からの提言
    　外科医からの提言

    ?．冠動脈疾患の手術適応と至適時期
    　1．冠動脈バイパス術
    　2．急性心筋梗塞における機械的合併症，
    　　　　左室内血栓に対する手術
    　3．虚血性僧帽弁逆流

    II．弁膜疾患の手術適応と至適時期
    　1．大動脈弁狭窄
    　2．大動脈弁逆流
    　3．僧帽弁狭窄
    　4．僧帽弁逆流
    　5．三尖弁逆流
    　6．感染性心内膜炎

    III．先天性心疾患および小児心疾患の手術適応と至適時期
    　1．心房中隔欠損症
    　2．心内膜床欠損症
    　3．心室中隔欠損症
    　4．Fallot四徴症
    　5．動脈管開存症
    　6．Ebstein奇形
    　7．Fontan手術適応例
    　8．川崎病
    　9．成人期の再手術−特に右室流出路再建−

    IV．大動脈疾患の手術適応と至適時期
    　1．大動脈解離
    　2．大動脈瘤

    ?．末梢血管疾患の手術適応と至適時期
    　1．閉塞性末梢動脈疾患
    　2．末梢血管疾患における再生医療

    VI．心不全の手術適応と至適時期
    　1．重症心不全に合併する僧帽弁閉鎖不全症
    　2．左室減容術
    　3．LVAS
    　4．心臓移植

    VII．他の重要な疾患の手術適応と至適時期
    　1．収縮性心膜炎
    　2．心房細動
    　3．肺動脈血栓塞栓症

    VIII．術前のリスク評価

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.13 掲載の参考文献
1) Edmond, M et al:Long-term survival of medically treated patients in the coronary artery surgery study(CASS)registry. Circulation 1994;90:2647-2657
 
2) Califf, RM et al:Tasc Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of factor management. J Am Coll Cardiol 1996;27:1009-1019
 
3) Mark, DB et al:Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 1994;89:2015-2025
 
4) Smith, LR et al:Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991;84(suppl III):III-245-III-253
 
5) Patel, MR et al:ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization:A report of the American College of Cardiology foundation appropriateness criteria task force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology:Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation 2009;119:1330-1352
 
6) Tonio, PA et al:Fractional flow reserve versus angioplasty for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-224
 
7) Botman, CJ et al:Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg 2007;83:2093-2097
 
8) Botman, KJ et al:Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement. Catheter Cardiovasc Interv 2004;63:184-191
 
9) Davis, RF et al:Asymptomatic cardiac ischemia pilot(ACIP)study two-year follow-up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-2043
 
10) The BARI investigators:The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-1606
 
11) Serruys, PW et al:Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124
 
12) Daemen, J et al:Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease:A meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118:1146-1154
 
13) Stettler, C et al:Outcomes associated with drug-eluting and bare-metal stents:A collaborative network meta-analysis. Lancet 2007;370:937-948
 
14) Kirtane, AJ et al:Safety and efficacy of drug-eluting and bare metal stents:Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009;119:3198-3206
 
15) Serruys, PW et al:5-Year clinical outcomes of the ARTS II(Arterial Revascularization Therapies Study II)of the Sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010;55:1093-1101
 
16) Serruys, PW et al:Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-972
 
17) Seung, KB et al:Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008;358:1781-1792
 
18) Morice, M-C et al:Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using Paclitaxel-eluting stents or coronary artery bypass graft in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery(SYNTAX) trial. Circulation 2010;121:2645-2653
 
19) Hlatky, MA et al:Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease:a collaborative analysis of individual patient data from ten randomized trials. Lancet 2009;373:1190-1197
 
20) Wijins, W et al:Guidelines on myocardial revascularization. The task force on myocardial revascularization of the European Society of Cardiology(ESC) and the European Association for Cardio-Thoracic Surgery(EACTS). Eur Heart J 2010;31:2501-2555
 
21) Stone, GW et al:Randomized comparison of everolimus-eluting and paclitaxel-eluting stents:Two-year clinical follow-up from the clinical evaluation of the Xience V everolimus-eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions(SPIRIT)III trial. Circulation 2009;119:680-686
 
22) Cremer, JT et al:Minimally invasive coronary artery revascularization on the beating heart. Ann Thorac Surg 2000;69:1787-1791
 
23) Cisowski, M et al:Integrated minimally invasive direct coronary artery bypass grafting and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg 2002;22:261-265
 
P.22 掲載の参考文献
1) Yusuf, S et al:Effect of coronary artery bypass graft on survival:overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-570
 
2) Muhlbaier, LH et al:Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease;20years of follow-up. Circulation 1992;86(suppl II):II-198-204
 
3) Hueb, W et al:Five-year follow-up of the Medicine, Angioplasty, or Surgery Study(MASS II):a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007;115:1082-1089
 
4) The BARI 2D Study Group;Frye, R et al:A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-2515
 
5) Hlatky, MA et al:Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease:a collaborative analysis of individual patients data from ten randomized trials. Lancet 2009;373:1190-1197
 
6) Serruys, PW et al:Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-972
 
7) Hannan, EL et al:Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005;352:2174-2183
 
8) Hannan, EL et al:Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-341
 
9) Kimura, T et al:Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation 2008;118(suppl 1):S199-S209
 
10) Malenka, DJ et al:Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI:analysis of BARI-like patients in northern New England. Circulation 2005;112:1371-1376
 
11) Eagle, KA et al:ACC/AHA 2004 Guideline update for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2004;110:e340-437
 
12) Kushner, FG et al:American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused Updates:ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction (updating the 2004 Guidelines and 2007 Focused Update)and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention(updating the 2005 Guideline and 2007 Focused Update):a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:2271-2306
 
13) Patel, MR et al:ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization:A report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology:Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society Cardiovascular Computed Tomography. Circulation 2009;119:1330-1352
 
14) Wijns, W et al:Guidelines on myocardial revascularization:The task force on myocardial revascularization of the European Society of Cardiology (ESC)and the European Association for Cardio-Thoracic Surgery(EACTS). Eur Heart J 2010;31:2501-2555
 
15) Naik, H et al:A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv 2009;2:739-747
PubMed
16) Park, EW et al:Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease:5-year results from the MAIN-COMPARE(Revascularization for Unprotected Left Main Coronary Artery Stenosis:Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 2010;56:117-124
 
17) Toyofuku, M et al:Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease-Insights from the j-cypher registry. Circulation 2009;120:1866-1874
 
18) The Bypass Angioplasty Revascularization Investigation(BARI)Investigators:Comparison of coronary artery bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-225
 
19) The BARI Investigators:The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-1606
 
20) Niles, NW et al:Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization:results of a large regional prospective study. J Am Coll Cardiol 2001;37:1008-1015
PubMed
21) Banning, AP et al:Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease. Copmarison of outcomes with cardiac surgery and Paclitaxel-Eluting stents. J Am Coll Cardiol 2010;55:1067-1075
 
22) Kapur, A et al:Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia(Coronary Artery Revascularization in Diabetes)Trial. J Am Coll Cardiol 2010;55:432-440
 
23) Graham, MM et al for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease(APPROACH)Investigators:Survival after coronary revascularization in the elderly. Circulation 2002;105:2378-2384
 
24) Dacey, LJ et al:Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease. Ann Thorac Surg 2007;84:1904-1911
 
25) Likosky, DS et al for the Northern New England Cardiovascular Disease Study Group:Long-term survival of the very elderly undergoing coronary artery bypass grafting. Ann Thorac Surg 2008;85:1233-1238
 
P.25 掲載の参考文献
1) Hachamovitch, R et al:Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-2906
 
2) Mets, LD et al:The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography. J Am Coll Cardiol 2007;49:227-237
 
3) Davies, RF et al:Asymptomatic cardiac ischemia pilot(ACIP)study two-year follow-up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-2043
 
4) Pijls, NHJ et al:Percutaneous coronary intervention of functionally nonsignificant stenosis. 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105-2111
 
5) Tonino, PAL et al:Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-224
 
6) Botman, CJ et al:Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement. Catheter Cardiovasc Interv 2004;63:184-191
 
7) Botman, CJ et al:Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg 2007;83:2093-2097
 
P.27 掲載の参考文献
1) Nesto, RW et al:The ischemic cascade:Temporal sequence of hemodynamic, electrocardiographic and symptomatic expression of ischemia. Am J Cardiol 1987;57:23C-27C
 
2) Cheitlin, MD et al:ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines(ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). Circulation 2003;108:1146-1162
 
3) Ishii, K et al:Exercise-induced post-ischemic left ventricular delayed relaxation or diastolic stunning. J Am Coll Cardiol 2009;53:698-705
PubMed
4) Kobayashi, A et al:Area strain by 3D wall motion tracking method is useful to detect adenosine-induced myocardial dysfunction;Comparison with 99mTc myocardial perfusion scintigraphy. Circulation 2009;120:S309-S310
 
P.29 掲載の参考文献
1) Rizzello, V et al:Comparison of long-term effect of coronary artery bypass grafting in patients with ischemic cardiomyopathy with viable versus nonviable left ventricular myocardium. Am J Cardiol 2004;94:757-760
 
2) Allman, KC et al:Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:a meta-analysis. J Am Coll Cardiol 2002;39:1151-1158
 
3) Beanlands, RSB et al:F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease:a randomized, controlled trial(PARR-2). J Am Coll Cardiol 2007;50:2002-2012
 
4) Wu, YW et al:Comparison of contrast-enhanced MRI with 18F-FDG PET/201Tl SPECT in dysfunctional myocardium:relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med 2007;48:1096-1103
 
P.31 掲載の参考文献
1) He, GW:Considerations in the choice of arterial grafts. Arterial Grafting for Coronary Artery Bypass Surgery, 2nd ed, Springer-Verlag, Berlin, 2006, 81-86
 
2) Buxton, BF et al:Choice of conduits for coronary artery bypass grafting:craft or science? Eur J Cardiothorac Surg 2009;35:658-670
PubMed
3) 北村惣一郎ほか:虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン, 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). Circ J 2006;70(suppl IV):1477-1553
 
4) Barner, HB:Operative treatment of coronary atherosclerosis. Ann Thorac Surg 2008;85:1473-1482
 
P.33 掲載の参考文献
1) Shroyer, AL et al:On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 2009;361:1827-1837
 
2) Calafiore, AM et al:Bilateral internal thoracic artery grafting with and without cardiopulmonary bypass:six-year clinical outcome. J Thorac Cardiovasc Surg 2005;130:340-345
 
3) Fukui, T et al:Early and midterm results of off-pump coronary artery bypass grafting. Ann Thorac Surg 2007;83:115-119
 
4) Suzuki, T et al:In off-pump surgery, skeletonized gastroepiploic artery is superior to saphenous vein in patients with bilateral internal thoracic arterial grafts. Ann Thorac Surg 2011;91:1159-1164
 
P.36 掲載の参考文献
1) Shahian, DM et al:The Society of Thoracic Surgeons 2008 cardiac surgery risk models:part 1 -coronary artery bypass grafting surgery-. Ann Thorac Surg 2009;88:S2-S22
 
2) 日本冠動脈外科学会全国アンケート調査委員会:冠動脈外科全国アンケート調査結果2009年, http://www.jacas.org/enquete/2009.html
 
P.38 掲載の参考文献
1) Carrel, T et al:The internal mammary artery malperfusion syndrome:incidence, treatment and angiographic verification. Eur J Cardiothorac Surg 1995;9:190-197
 
2) Katz, MG et al:Nonocclusive mesenteric ischemia after off-pump coronary artery bypass surgery:A word of caution. Am Surg 2006;72:228-231
 
3) Peel, GK et al:Chronologic distribution of stroke after minimally invasive versus conventional coronary artery bypass. J Am Coll Cardiol 2004;43:752-756
 
4) Doi, K et al:Importance of cerebral artery risk evaluation before off-pump coronary artery bypass grafting to avoid perioperative stroke. Eur J Cardiothorac Surg 2010;38:568-572
 
5) Kronzon, I et al:Cholesterol embolization syndrome. Circulation 2010;122:631-641
 
P.40 掲載の参考文献
1) Johkers, D et al:Prevalence of 90-day postoperative wound infections after cardiac surgery. Eur J Cardiothorac Surg 2003;23:97-102
 
2) Manabe, S et al:Arterial graft deterioration on year after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2010;140:1306-1311
 
3) Sabik, JF III et al:Does competitive flow reduce internal thoracic artery graft patency? Ann Thorac Surg 2003;76:1490-1497
 
4) Meurin, P et al:Evolution of the postoperative pericardial effusion after day 15. The problem of the late tamponade. Chest 2004;125:2182-2187
 
5) Light, RW et al:Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med 2002;166:1567-1571
 
P.42 掲載の参考文献
1) Rosenhek, R et al:Natural history of severe aortic stenosis. Circulation 2010;121:151-156
 
2) Rosenhek, R et al:Mild and moderate aortic stenosis natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199-205
 
3) 日本冠動脈外科学会全国アンケート調査委員会:冠動脈外科全国アンケート調査結果2009年, http://www.jacas.org/enquete/2009.html
 
4) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008. Gen Thorac Cardiovascular Surg 2010;58:356-383
 
5) Ahmed, AAM et al:Management of mild to moderate aortic valve disease during coronary artery bypass grafting. Eur J Cardiothorac Surg 2003;24:535-540
 
6) Fiore, AC et al:Management of asymptomatic mild aortic stenosis during coronary artery operations. Ann Thorac Surg 1996;61:1697-1698
 
7) Odell, JA et al:Aortic valve replacement after previous coronary artery bypass grafting. Ann Thorac Surg 1996;62:1424-1430
 
8) Faggiano, P et al:Rate of progression of valvular aortic stenosis in adults. Am J Cardiol 1992;70:229-233
 
9) Otto, CM et al:Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-2270
 
10) Sareyyupoglu, B et al:Management of mild aortic stenosis at the time of coronary artery bypass surgery:Should the valve be replaced? Ann Thorac Surg 2009;88:1224-1231
 
P.49 掲載の参考文献
1) 丸山幸夫ほか:急性心不全治療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2006_maruyama_h.pdf(2011年8月閲覧)
 
2) Birnbaum, Y et al:Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction. Am J Cardiol 2000;86:830-834
 
3) Crenshaw, BS et al:Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation 2000;101:27-32
 
4) Menon, V et al:Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction:a report from the shock trial registry. should we emergently revascularize occluded coronaries in cardiogenic shock? J Am Coll Cardiol 2000;36:1110-1116
 
5) Lemery, R et al:Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol 1992;70:147-151
 
6) Figueras, J et al:Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation 2008;118:2783-2789
 
7) Moreno, R et al:Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2002;39:598-603
 
8) Hochman, JS et al:Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome:a report from the shock trial registry. should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36:1063-1070
 
9) Thompson, CR et al:Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction:a report from the shock trial registry. should we use emergently revascularize occluded coronaries in cardiogenic shock? J Am Coll Cardiol 2000;36:1104-1109
 
10) Kinn, JW et al:Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. Cathet Cardiovasc Diagn 1997;42:151-157
 
P.55 掲載の参考文献
1) Antman, EM et al:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 2004;44:E1-E211
 
2) Caimmi, PP et al:Double patch repair through a single ventriculotomy for ischemic ventricular septal defects. Ann Thorac Surg 2010;89:1679-1681
 
3) 小宮達彦ほか:80歳以上の高齢者に対する心室中隔穿孔急性期の手術. 胸部外科 1997;50:610-613
 
4) Murashita, T et al:The clinical challenge to reduce the postoperative residual shunt in surgical repair of postinfarction ventricular septal perforation. Interact Cardiovasc Thorac Surg 2010;11:38-41
 
5) Attia, R et al:Which patients might be suitable for a septal occluder device closure of postinfarction ventricular septal rupture rather than immediate surgery? Interact Cardiovasc Thorac Surg 2010;11:626-629
 
6) Lundblad, R et al:Surgical repair of postinfarction ventricular septal rupture:Risk factors of early and late death. J Thorac Cardiovasc Surg 2009;137:862-868
 
7) Fukushima, S et al:Determinants of in-hospital and long-term surgical outcomes after repair of postinfarction ventricular septal rupture. J Thorac Cardiovasc Surg 2010;140:59-65
 
8) Papadopoulos, N et al:Long-term results after surgical repair of postinfarction ventricular septal rupture by infarct exclusion technique. Ann Thorac Surg 2009;87:1421-1425
 
9) 日本冠動脈外科学会全国アンケート調査委員会:冠動脈外科全国アンケート調査結果 2009年, http://www.jacas.org/enquete/2009.html
 
10) Padro, JM et al:Subacute cardiac rupture:repair with a sutureless technique. Ann Thorac Surg 1993;55:20-24
 
11) 小宮達彦ほか:急性心筋梗塞に合併した亜急性型左室自由壁破裂に対する外科治療:特に心膜パッチ接着法について. 日胸外会誌 1996;44:806-810
 
12) Sakaguchi, G et al:Surgical treatment for postinfarction left ventricular free wall rupture. Ann Thorac Surg 2008;85:1344-1347
 
13) Alcazar, MC et al:Short-term and mid-term follow-up of sutureless surgery for postinfarction subacute free wall rupture. Interact Cardiovasc Thorac Surg 2009;8:619-623
 
14) Frances, C et al:Left ventricular pseudoaneurysm. J Am Coll Cardiol 1998;32:557-561
 
15) Russo, A et al:Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation 2008;118:1528-1534
 
16) Sponga, S et al:Mitral valve repair after papillary muscle rupture through beating heart adjustment of artificial chordae length. Ann Thorac Surg 2010;90:e32-33
 
17) Osherov, AB et al:Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era. Am Heart J 2009;157:1074-1080
 
18) Tsukube, T et al:Transaortic video-assisted removal of a left ventricular thrombus. Ann Thorac Surg 1999;68:1063-1065
 
19) Early, GL et al:Simplified method of left ventricular thrombectomy. Ann Thorac Surg 2001;72:953-954
 
P.62 掲載の参考文献
1) Grigioni, F et al:Ischemic mitral regurgitation:long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-1764
 
2) Otsuji, Y et al:Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation:direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997;96:1999-2008
 
3) Keren, G et al:Effect of isometric exercise on cardiac performance and mitral regurgitation in patients with severe congestive heart failure. Am Heart J 1989;118:973-979
 
4) Heuser, RR et al:Coronary angioplasty for acute mitral regurgitation due to myocardial infarction. Ann Intern Med 1987;107:852-855
 
5) Aklog, L et al:Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001;104(suppl 1):I68-I75
 
6) Hickey, MS et al:Current prognosis of ischemic mitral regurgitation:implications for future management. Circulation 1988;78(suppl I):I51-I59
 
7) Bolling, SF et al:Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381-388
 
8) Calafiore, AM et al:Mitral valve procedure in dilated cardiomyopathy:repair or replacement? Ann Thorac Surg 2001;71:1146-1152
 
9) Zhu, F et al:Mechanism of persistent ischemic mitral regurgitation following annuloplasty:importance of augmented posterior mitral leaflet tethering. Circulation 2005;112(suppl I):I-396-I-401
 
10) Magne, J et al:Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 2008;51:1692-1701
 
11) Marwick, TH:Restrictive annuloplasty for ischemic mitral regurgitation:too little or too much? J Am Coll Cardiol 2008;51:1702-1703
PubMed
12) Kubota, K et al:Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation:importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. J Thorac Cardiovasc Surg 2010;140:617-623
 
P.68 掲載の参考文献
1) Bursi, F et al:Heart failure and death after myocardial infarction in the community:the emerging role of mitral regurgitation. Circulation 2005;111:295-301
 
2) Grigioni, F et al:Ischemic mitral regurgitation:long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-1764
 
3) Otsuji, Y et al:Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction:three dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol 2001;37:641-648
 
4) Enriquez-Sarano, M:Timing of mitral valve surgery. Heart 2002;87:79-85
 
5) Gillinov, AM et al:Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001;122;1125-1141
 
6) Miller, DC:Ischemic mitral regurgitation redux-to repair or to replace? J Thorac Cardiovasc Surg 2001;122:1059-1062
PubMed
7) Lam, B-K et al:Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg 2005;79:462-470
 
8) Di Mauro, M et al:Impact of no-to-moderate mitral regurgitation on late results after isolated coronary artery bypass grafting in patients with ischemic cardiomyopathy. Ann Thorac Surg 2006;81:2128-2134
 
9) Mihaljevic, T et al:Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191-2201
 
10) Kim, YH et al:Ischemic mitral regurgitation:revascularization alone versus revascularization and mitral valve repair. Ann Thorac Surg 2005;79:1895-1901
 
11) Harris, KM et al:Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg 2002;74:1468-1475
 
12) Fattouch, K et al:POINT:efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation:a randomized trial. J Thorac Cardiovasc Surg 2009;138:278-285
 
13) Mihaljevic, T et al:Functional ischemic mitral regurgitation:myocardial viability as a predictor of postoperative outcome after isolated coronary artery bypass grafting. Circulation 2009;120:1459-1461
 
14) Penicka, M et al:Predictors of improvement of unpaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation 2009;120:1474-1481
 
15) Authors/Task Force Members:Guidelines on myocardial revascularization:the task force on myocardial revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS). Eur J Cardiothorac Surg 2010;38:S1-S52
 
16) Calafiore, AM et al:Mitral valve procedure in dilated cardiomyopathy:repair or replacement? Ann Thorac Surg 2001;71:1146-1153
 
17) Magne, J et al:Mitral repair versus replacement for ischemic mitral regurgitation:comparison of short-term and long-term survival. Circulation 2009;120(suppl 1):S104-S111
 
18) Vassileva, CM et al:Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011;39:295-303
 
19) Mastunaga, A et al:Failure of reduction annuloplasty for functional ischemic mitral regurgitation. J Heart Valv Dis 2004;13:390-398
 
20) Kuwahara, E et al:Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty:importance of augmented posterior leaflet tethering. Circulation 2006;114:I-529-I-534
 
21) Magne, J et al:Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral annuloplasty for ischemic mitral regurgitation. Circulation 2007;115:782-791
 
22) Kongsaerepong, V et al:Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am J Cardiol 2006;98:505-508
 
23) Braun, J et al:Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008;85:430-437
 
24) Kincaid, EH et al:Anterior leaflet augmentation for ischemic mitral regurgitation. Ann Thorac Surg 2004;78:564-568
PubMed
25) Dobre, M et al:Anatomic and physiologic correction of the restricted posterior mitral leaflet motion in chronic ischemic regurgitation. J Thorac Cardiovasc Surg 2000;120:409-411
 
26) De Varennes, B et al:Initial results of posterior leaflet extension for severe type IIIb ischemic mitral regurgitation. Circulation 2009;119:2837-2843
 
27) Messas, E et al:Chordal cutting:a new therapeutic approach for ischemic mitral regurgitation. Circulation 2001;104:1958-1963
 
28) Borger, MA et al:Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007;133:1483-1492
 
29) Hvass, U et al:Papillary muscle sling:a new functional approach to mitral repairs in patients with ischemic left ventricular dysfunction and functional mitral regurgitation. Ann Thorac Surg 2003;75:809-811
 
30) Hvass, U et al:The papillary muscle sling for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2010;139:418-423
 
31) Kron, IL et al:Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 2002;74:600-601
 
32) Langer, F et al:RING plus STRING:papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007;133:247-249
 
33) Langer, F et al:RING+STRING:successful repair technique for ischemic mitral regurgitation with severe leaflet tethering. Circulation 2009;120(suppl 1):S85-S91
 
34) Yamazaki, S et al:Surgical relocation of the papillary muscles in ischemic mitral regurgitation resulted from excessive remodeling. Inovations 2010;5(abst):237
 
35) Menicanti, L et al:Ischemic mitral regurgitation:intraventricular papillary muscle imbrications without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg 2002;123:1041-1050
 
36) Matsui, Y et al:Integrated overlapping ventriculoplasty combined with papillary muscle placation for severely dilated heart failure. J Thorac Cardiovasc Surg 2004;127:1221-1223
 
37) Liel-Cohen, N et al:Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation. Circulation 2000;101:2756-2763
 
38) Yaku, H et al:Endocardial linar infarct exclusion technique for lateral wall:a new technique for ventricular restoration(Abst). Interact Cardiovasc Thorac Surg 2008;7(suppl 3):S254
 
39) Magne, J et al:restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 2008;51:1692-1701
 
40) Kubota, K et al:Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation:Importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. J Thorac Cardiovasc Surg 2010;140:617-623
 
41) Williams, ML et al:Mitral gradients and frequency of of recurrence of mitral regurgitation after ring annuloplasty for ischemic mitral regurgitation. Ann Thorac Surg 2009;88:1197-1201
 
P.74 掲載の参考文献
1) Otsuji, Y et al:Isolated annular dilatation does not usually cause important functional mitral regurgitation:comparison between patients with lone atrial fibrillation and idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol 2002;39:1651-1656
 
2) McCully, BR et al:Overestimation of severity of ischemic/functional mitral regurgitation by color Doppler jet area. Am J Cardiol 1994;74:790-793
 
3) Bonow, RO et al:2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-e142
 
4) Calafiore, AM:Mitral valve procedure in dilated cardiomyopathy:repair or replacement? Ann Thorac Surg 2001;71:1146-1152
 
5) Lee, AP et al:Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy:importance of distal anterior leaflet tethering. Circulation 2009;119:2606-2614
 
P.76 掲載の参考文献
1) Grewal, KS et al:Effect of general anesthesia on the severity of mitral regurgitation by transesophageal echocardiography. Am J Cardiol 2000;85:199-203
 
2) Otsuji, Y et al:Effect of general anesthesia on the severity of mitral regurgitation by transesophageal echocardiography. J Am Coll Cardiol 2001;37:641-648
 
3) Aklog, L et al:Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001;104(suppl 1):I68-I75
 
4) Shiran, A et al:Intraoperative transesophageal echocardiography using a quantitative dynamic loading test for the evaluation of ischemic mitral regurgitation. J Am Soc Echocardiogr 2007;20:690-697
 
5) Michelena, HI et al:Intraoperative echocardiography in valvular heart disease:An evidence-based appraisal. Mayo Clin Proc 2010;85:646-655
 
P.78 掲載の参考文献
1) Borger, MA et al:Chronic ischemic mitral regurgitation:repair, replace or rethink? Ann Thorac Surg 2006;81:1153-1161
PubMed
2) Calafiore, AM et al:Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg 2004;77:1989-1997
 
3) Mihaljevic, T et al:Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007;49:2191-2201
 
4) Enriquez-Sarano, M et al:Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-883
 
5) Bach, DS et al:Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 1995;129:1165-1170
 
6) Kuwahara, E et al:Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty:importance of augmented posterior leaflet tethering. Circulation 2006;114(1 suppl):I529-I534
 
7) Dor, V et al:Left ventricular aneurysm:a new surgical approach. Thorac Cardiovasc Surg 1989;37:11-19
 
8) Ferrazzi, P et al:Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy:The relevance of the left ventricular equator as a prognostic factor. J Thorac Cardiovasc Surg 2006;131:357-363
 
9) Liel-Cohen, N et al:Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation:insights from 3-Dimensional echocardiography. Circulation 2000;101:2756-2763
 
10) Langer, F et al:RING plus STRING:Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007;133:247-249
 
11) Kron, IL et al:Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 2002;74:600-601
 
12) Alfieri, O et al:The double-orifice technique in mitral valve repair:A simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-681
 
13) Fukui, T et al:Mild or moderate ischemic mitral regurgitation in patients undergoing off-pump coronary artery bypass grafting. J Card Surg 2007;22:480-485
 
P.87 掲載の参考文献
1) Iung, B et al:A prospective survey of patients with valvular heart disease in Europe:The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243
 
2) Stewart, BF et al:Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634
 
3) Otto, CM et al:Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147
 
4) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
5) Bonow, RO et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2006;48:e1-148
 
6) Vahanian, A et al:Guidelines on the management of valvular heart disease. Eur Heart J 2007;28:230-268
 
7) Oh, JK et al:The Echo Manual, 3rd ed, Lippincott Williams & Wilkins, Philadelphia, 2006
 
8) Bonow, RO et al:ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-1588
 
9) Kang, DH et al:Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010;121:1502-1509
 
10) Iung, B et al:Decision-making in elderly patients with severe aortic stenosis:why are so many denied surgery? Eur Heart J 2005;26:2714-2720
 
11) Thomas, M et al:Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE)registry. A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;112:62-69
 
12) Leon, MB et al:Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607
 
P.91 掲載の参考文献
1) Iung, B et al:A prospective survey of patients with valvular heart disease in Europe:The Euro Heart Survey on valvular heart disease. Eur Heart J 2003;24:1231-1243
 
2) Nkomo, VT et al:Burden of valvular heart diseases:a population-based study. Lancet 2006;368:1005-1011
 
3) Bonow, RO et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2006;48:e1-148
 
4) Vahanian, A et al:Guidelines on the management of valvular heart disease. Eur Heart J 2007;28:230-268
 
5) 松田 暉ほか:弁膜疾患の非薬物療法に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
6) Bach, DS et al:Unoperated patients with severe stenosis. J Am Coll Cardiol 2007;50:2018-2019
 
7) Brown, JM et al:Isolated aortic valve replacement in north America comprising 108,687 patients in 10 years:Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovas Surg 2009;137:82-90
 
8) Sundt, TM et al:Quality of life after aortic valve replacement at the age of>80 years. Circulation 2000;102:III-70-III-74
 
9) Faggiano, P et al:Prevalence of comorbidities and associated cardiac diseases in patients with valve aortic stenosis. Potential implications for the decision-making process. Int J Cardiol 2011[Epub ahead of print]
 
10) Motomura, N et al:Risk model of valve surgery in Japan using the Japan adult cardiovascular surgery database. J Heart Valve Dis 2010;19:684-669
 
11) Borger, MA et al:Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg 2004;128:677-683
 
12) Blais, C et al:Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003;108:983-988
 
13) Bach, DS et al:Subvalvular left ventricular outflow obstruction for patients undergoing aortic valve replacement for aortic stenosis;Echocardiographic recognition and identification of patients at risk. J Am Soc Echocardiogr 2005;18:1155-1162
 
P.93 掲載の参考文献
1) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
2) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_d.pdf(2011年8月閲覧)
 
3) Bergoend, E et al:20 years' durability of Carpentier-Edwards perimount atented pericardial aortic valve. Aortic Root Surgery, Springer, Berlin, 441-451, 2010
 
4) David, TE et al:Hancock II bioprosthesis for aortic valve replacement:The gold standard of bioprosthetic valves durability. Ann Thorac Surg 2010;90:775-781
 
5) Davierwala, PM et al:Reoperation is not an independent predictor of mortality during aortic valve surgery. J Thorac Cradiovasc Surg 2006;131:329-335
 
P.95 掲載の参考文献
1) Rahimtoola, SH:The problem of valve prosthesis-patient mismatch. Circulation 1978;58:20-24
 
2) Dumesnil, JG et al:Validation and applications of indexed aortic prosthetic valve areas calculated by Doppler echocardiography. J Am Coll Cardiol 1990;16:637-643
 
3) Pibarot, P et al:Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000;36:1131-1141
 
4) Florath, I et al:Impact of valve prosthesis-patient mismatch estimated by echocardiographic-determined effective orifice area on long-term outcome after aortic valve replacement. Am Heart J 2008;155:1135-1142
 
5) Jamieson, WR et al:Effect of prosthesis-patient mismatch on long-term survival with aortic valve replacement:assessment to 15 years. Ann Thorac Surg 2010;89:51-58
 
6) Blais, C et al:Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003;108:983-988
 
7) Rao, V et al:Prosthesis-patient mismatch affects survival after aortic valve replacement. Circulation 2000;102(suppl 3):III5-III9
 
8) Mohty, D et al:The impact of prosthesispatient mismatch on long-term survival in patients with small St Jude Medical mechanical prostheses in the aortic position. Circulation 2006;113:420-426
 
9) Urso, S et al:Is patient-prosthesis mismatch an independent risk factor for early and mid-term overall mortality in adult patients undergoing aortic valve replacement? Interact Cardiovasc Thorac Surg 2009;9:510-518
 
10) 山田 聡:Pressure recovery が問題になる時, ならない時. 新・心臓病診療プラクティス 17 大動脈弁・僧帽弁疾患を心エコー図で診る・活かす, 文光堂, 東京, 2011, 28-31
 
P.97 掲載の参考文献
1) Iung, B et al:A prospective survey of patients with valvular heart disease in Europe:The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243
 
2) Hara, H et al:Percutaneous balloon aortic valvuloplasty revisited:time for a renaissance? Circulation 2007;115:e334-338
 
3) Leon, MB et al:PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607
 
4) Thomas, M et al:Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE)Registry:A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-69
 
5) Tamburino, C et al:Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308
 
P.99 掲載の参考文献
1) Hattori, K et al:Apico-aortic bypass and concomitant replacement of a descending aorta containing severe atherosclerotic plaques. Eur J Cardiothorac Surg 2010;37:1229
PubMed
2) Hattori, K et al:Images in cardiovascular medicine. Apico-biaxillary bypass for an aortic stenosis patient with severe calcification of the entire aorta. Circulation 2010;121:e447-e449
 
3) Kotani, S et al:Thrombus in the distal aortic arch after apicoaortic conduit for severe aortic stenosis. Interact CardioVasc Thorac Surg 2010;10:486-488
 
P.101 掲載の参考文献
1) Varadarajan, P et al:Survival in elderly patients with severe aortic stenosis is dramatically improved aortic valve replacement:results from a cohort of 277 patients aged>or=80 years. Eur J Cardiothorac Surg 2006;30:722-727
PubMed
2) Dalrymple-Hay, MJ et al:Cardiac surgery in the elderly. Eur J Cardiothoracic Surg 1999;15:61-66
 
3) Likosky, DS et al:Long-term survival of the very elderly undergoing coronary artery bypass grafting. Ann Thorac Surg 2008;85:1233-1238
 
4) Rohde, SL et al:Preoperative and intraoperative factors associated with long-term survival in octogenarian cardiac surgery patients. Ann Thorac Surg 2010;89:105-111
 
5) Bardakci, H et al:Discharge to home rates are significantly lower for octogenarians undergoing coronary artery bypass graft surgery. Ann Thorac Surg 2007;83:483-489
 
P.107 掲載の参考文献
1) le Polain de Waroux, JB et al:Functional anatomy of aortic regurgitation:accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography. Circulation 2007;116:I264-I269
 
2) Boodhwani, M et al:Repair-oriented classification of aortic insufficiency:impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg 2009;137:286-294
 
3) Cotrufo, M et al:Aortic valve dysfunction and dilated ascending aorta. A complex and controversial association. Ital Heart J 2003;4:589-595
 
4) Bonow, RO et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease):developed in collaboration with the Society of Cardiovascular Anesthesiologists:endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231
 
5) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
P.112 掲載の参考文献
1) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版). 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
2) Bonow, RO et al:2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation 2008;118:e523-e661
 
3) Vahanian, A et al:Guidelines on the management of valvular heart disease:The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology;ESC Committee for Practice Guidelines. Eur Heart J 2007;28:230-268
 
4) Taniguchi, K et al Left ventricular mass:impact on left ventricular contractile function and its reversibility in patients undergoing aortic valve replacement. Eur J Cardiothorac Surg 2007;32:588-595
 
5) Detaint, D et al:Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation:a prospective study. JACC Cardiovasc Imaging 2008;1:1-11
 
6) Detaint, D et al:Congestive heart failure complicating aortic regurgitation with medical and surgical management:a prospective study of traditional and quantitative echocardiographic markers. J Thorac Cardiovasc Surg 2008;136:1549-1557
 
7) Pai, RG et al:Prognostic implications of mitral regurgitation in patients with severe aortic regurgitation. Circulation 2010;122(suppl 1):S43-S46
 
8) Sambola, A et al:Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. Am Heart J 2008;155:1114-1120
 
9) Brown, ML et al:Indexed left ventricular dimensions best predict survival after aortic valve replacement in patients with aortic valve regurgitation. Ann Thorac Surg 2009;87:1170-1175, discussion 1175-1176, Erratum in:Ann Thorac Surg 2009;88:710
 
10) Turk, R et al:Survival benefit of aortic valve replacement in older patients with asymptomatic chronic severe aortic regurgitation. Ann Thorac Surg 2010;89:731-737
 
11) Taniguchi, K et al:Preoperative left ventricular function:minimal requirement for successful late results of valve replacement for aortic regurgitation. J Am Coll Cardiol 1987;10:510-518
 
12) Taniguchi, K et al:Depressed myocardial contractility and normal ejection performance after aortic valve replacement in patients with aortic regurgitation. J Thorac Cardiovasc Surg 1989;98:258-265
 
13) Taniguchi, K et al:Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation 1990;82:798-807
 
14) Bhudia, SK et al:Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction. J Am Coll Cardiol 2007;49:1465-1471
 
15) Kamath, AR et al:Survival in patients with severe regurgitation and severe left ventricular dysfunction is improved by aortic valve replacement. Results from a cohort of 166 patients with an ejection fraction <=35%. Circulation 2009;120:S134-S138
PubMed
P.114 掲載の参考文献
1) Bonow, RO et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease)developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-e148
 
2) Tadros, TM et al:Ascending aortic dilatation associated with bicuspid aortic valve:pathophysiology, molecular biology, and clinical implications. Circulation 2009;119:880-890
 
P.116 掲載の参考文献
1) Schafers, H-J et al:Preservation of the bicuspid aortic valve. Ann Thorac Surg 2007;83:S740-S745
 
2) El Khoury, G et al:Repair of aortic valve prolapse:experience with 44patients. Eur J Cardiothorac Surg 2004;26:628-633
 
3) Schafers, H-J et al:A new approach to the assessment of aortic cusp geometry. J Thorac Cardiovasc Surg 2006;132:436-438
 
4) Boodhwani, M et al:Repair-oriented classification of aortic insufficiency:Impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg 2009;137:286-294
 
5) Aicher, D et al:Cusp repair in aortic valve reconstruction:Does the technique affect stability? J Thorac Cardiovasc Surg 2007;134:1533-1539
 
P.118 掲載の参考文献
1) Taniguchi, K et al:Preoperative left ventricular function:minimal requirement for successful results of valve replacement for aortic regurgitation. J Am Coll Cardiol 1987;10:510-518
 
2) Villari, B et al:Persistent diastolic dysfunction late after valve replacement in severe aortic regurgitation. Circulation 2009;120:2386-2392
 
3) Dujardin, KS et al:Mortality and morbidity of aortic regurgitation in clinical practice:a long-term follow-up study. Circulation 1999;99:1851-1857
 
4) Arnow, WS et al:Prognosis of patients with heart failure and unoperated severe aortic valvular regurgitation and relation to ejection fraction. Am J Cardiol 1994;74:286-288
 
5) Henry, WL et al:Observations on the optimum time for operative intervention for aortic regurgitation. I. evaluation of the results of aortic valve replacement in symptomatic patients. Circulation 1980;61:471-483
 
6) Chaliki, HP et al:Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002;106:2687-2693
 
P.122 掲載の参考文献
1) Olson, LJ et al:Surgical pathology of the mitral valve:a study of 712 cases spanning 21 years. Mayo Clin Proc 1987;62:22-34
 
2) Wilkins, GT et al:Percutaneous balloon dilatation of the mitral valve:an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308
 
3) Kim, KC et al:Long-term results of the Cox-maze III procedure for persistent atrial fibrillation with rheumatic mitral valve disease:10-year experience. Eur J Cardiothorac Surg 2007;31:261-266
 
4) Song, H et al:Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation 2007;116:I246-I250
 
5) Bonow, RO et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 2006;114:e84-e231
 
6) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
7) Inoue, K et al:Clinical application of transvenous mitral commissurectomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984;87:394-402
 
8) Iung, B et al:Immediate results of percutaneous mitral commissurectomy. A prospective model on a series of 1514 patients. Circulation 1996;94:2124-2130
 
9) Palacios, IF et al:Which patients benefit from percutaneous mitral balloon valvuloplasty variables that predict long-term outcome. Circulation 2002;105:1465-1471
 
10) Fawzy, ME et al:Long-term clinical and echocardiographic results after successful mitral balloon valvotomy and predictors of long-term outcome. Eur Heart J 2005;26:1647-1652
 
P.127 掲載の参考文献
1) Cohn, LH et al:Long-term results of open mitral valve reconstruction for mitral stenosis. Am J Cardiol 1985;55:731-734
 
2) Inoue, K et al:Clinical application of trnsvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984;87:394-402
 
3) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
4) Bando, K et al:Early and late stroke after mitral valve replacement with a mechanical prosthesis:risk factor analysis of a 24-year experience. J Thorac Cardiovasc Surg 2003;126:358-364
 
5) Sellors, TH et al:Valvotomy in the treatment of mitral stenosis. Br Med J 1953;2:1059-1067
 
6) Wilkins, GT et al:Percutaneous balloon dilatation of the mitral valve:an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308
 
7) Glower, DD et al:Comparison of open mitral commissurotomy with mital valve replacement with or without chordal preservation in patients with mitral stenosis. Circulation 1998;98(suppl II):120-123
 
8) Okita, Y et al:Mitral valve replacement with maintenance of mitral annulo-papillary muscle continuity in patients with mitral stenosis. J Thorac Cardiovasc Surg 1994;108:42-51
 
P.129 掲載の参考文献
1) Inoue, K et al:Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thoracic Cardiovasc Surg 1984;87:394-402
 
2) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版). 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
3) Wilkins, GT et al:Percutaneous balloon dilatation of the mitral valve:an analysis of echocardiac valiables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308
 
4) 延吉正清ほか:PTMC の効果と合併症. 肺と心1990;37:109-117
 
5) Ommen, SR et al:Comparison of long-term results of percutaneous mitral balloon valvotomy with closed transventricular mitral commissurotomy at a single North American Institution. Am J Cardiol 1999;84:575-577
 
6) Hernandez, R et al:Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation 1999;99:1580-1586
 
7) Hamasaki, N et al;Ten-years clinical follow-up following successful percutaneous transvenous mitral commissurotomy:single-center experience. Catheter Cardiovasc Interv 2000;49:284-288
 
8) Ben-Farhat, M et al:Predictors of long-term event-free survival and of freedom from restenosis after percutaneous balloon mitral commissurotomy. Am Heart J 2001;142:1072-1079
 
9) Chmielak, Z et al:Long-term follow-up of patients with percutaneous mitral commissurotomy. Kardiol Pol 2008;66:525-532
 
10) 廣澤弘七郎:心臓病の自然歴, 医学書院, 東京, 1995, 163-167
 
P.131 掲載の参考文献
1) 笠貫 宏ほか:不整脈の非薬物治療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2005年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2006_kasanuki_h.pdf(2011年8月閲覧)
 
2) Bando, K et al:Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease. J Thorac Cardiovasc Surg 2002;124:575-583
 
3) Kim, H et al:Mid-term results of the Cox maze III procedure combined with open mitral commissurotomy for the treatment of rheumatic mitral stenosis. Circ J 2010;74:1332-1338
 
4) Nitta, T et al:Map-guided surgery for atrial fibrillation. J Thorac Cardiovasc Surg 2005;129:291-299
 
5) Marui, A et al:A novel atrial volume reduction technique to enhance the cox maze procedure:Initial results. J Thorac Cardiovasc Surg 2006;132:1047-1053
 
P.135 掲載の参考文献
1) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
2) Bonow, RW et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006;48:e1-148
 
3) Zoghbi, WA et al:Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802
 
4) Enriquez-Sarano, M et al:Early surgery is recommended for mitral regurgitation. Circulation 2010;121:804-811
 
5) Suri, RM et al:Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse. J Thorac Cardiovasc Surg 2009;137:1071-1076
 
6) Takasaki, K et al:Detection of left ventricular dysfunction with Tei index in normal ejection fraction patients with mitral regurgitation before mitral valve surgery. Am J Cardiol 2009;103:1011-1014
 
7) Gillam, LD et al:Primum non nocere:the case for watchful waiting in asymptomatic "severe" degenerative mitral regurgitation. Circulation 2010;121:813-821
PubMed
P.139 掲載の参考文献
1) Enriquez-Sarano, M et al:Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-883
 
2) Bonow, RO et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease):developed in collaboration with the Society of Cardiovascular Anesthesiologists:endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231
 
3) Ling, LH et al:Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417-1423
 
4) Tribouilloy, CM et al:Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation:rationale for optimizing surgical indications. Circulation 1999;99:400-405
 
5) Crawford, MH et al:Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation 1990;81:1173-1181
 
6) Enriquez-Sarano, M et al:Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022-1028
 
7) Rosenhek, R et al:Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006;113:2238-2244
 
8) Ling, LH et al:Early surgery in patients with mitral regurgitation due to flail leaflets:a long-term outcome study. Circulation 1997;96:1819-1825
 
9) Enriquez-Sarano, M et al:Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-837
 
P.141 掲載の参考文献
1) Wiggers, CJ et al:The contour of the ventricular volume curves under different conditions. Am J Physiol 1922;58:439-475
 
2) Hetzer, R et al:Preservation of papillary muscles and chordae during mitral valve replacement:possibilities and limitations. J Heart Valve Dis 1995;4(suppl 2):S115-S123
 
3) Okita, Y et al:Left ventricular function after mitral valve replacement with or without chordal preservation. J Heart Valve Dis 1995;4(suppl 2):S181-192, discussion S192-S193
 
4) Takayama, Y et al:Enhanced regional deformation at the anterior papillary muscle insertion site after chordal transsection. Circulation 1996;93:585-593
 
5) Thomson, LE et al:Entrapment of mitral chordal apparatus causing early postoperative dysfunction of a St. Jude mitral prosthesis. J Am Soc Echocardiogr 2002;15:843-844
 
6) Hassouna, A et al:Valve replacement in rheumatic mitral incompetence:total versus posterior chordal preservation. Cardiovasc Surg 1998;6:133-138
 
7) Yun, KL et al:Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement:effects on left ventricular volume and function. J Thorac Cardiovasc Surg 2002;123:707-714
 
8) Okita, Y et al:Replacement of chordae tendineae using expanded polytetrafluoroethylene(ePTFE) sutures during mitral valve replacement in patients with severe mitral stenosis. J Card Surg 1993;8:567-578
 
9) Okita, Y et al:Mid-term results of mitral valve replacement combined with chordae tendineae replacement in patients with mitral stenosis. J Heart Valve Dis 1997;6:37-42
 
10) Garcia-Fuster, R et al:Mitral valve replacement in rheumatic patients:effects of chordal preservation. Ann Thorac Surg 2008;86:472-481, discussion 481
PubMed
11) Gillinov, AM et al:Pre-measured artificial chordae for mitral valve repair. Ann Thorac Surg 2007;84:2127-2129
 
P.143 掲載の参考文献
1) Bhudia, SK et al:Mitral valve surgery in the adult Marfan syndrome patient. Ann Thorac Surg 2006;81:843-848
 
2) Fuzellier, JF et al:Surgical management of mitral regurgitation associated with Marfan's syndrome. Ann Thorac Surg 1998;66:68-72
 
3) Gillinov, AM et al:Mitral valve operation in patients with the Marfan syndrome. J Thorac Cardiovasc Surg 1994;107:724-731
 
4) Morita, S et al:Extensive use of artificial chordae for repairing diffuse mitral valve prolapse. Ann Thorac Surg 1996;62:878-880
 
5) Takano, H et al:Successful mitral valve replacement in a patient with Ehlers-Danlos syndrome type VI. Ann Thorac Surg 2005;80:320-322
 
6) 北川学代ほか:Ehlers-Danlos 症候群による僧帽弁閉鎖不全症に対する1 手術例. 日胸外会誌 1984;32:1073-1077
 
7) Sauer, M et al:Successful surgical treatment of atrial fibrillation, mitral regurgitation, and aortic root aneurysm in a patient with classical type Ehlers-Danlos syndrome. Ann Thorac Surg 2010;89:273-275
 
8) Loeys, BL et al:Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006;355:788-798
 
P.145 掲載の参考文献
1) Lambert, A-S et al:Improved evaluation of the location and mechanism of mitral valve regurgitation with a systematic transesophageal echocardiography examination. Anesth Analg 1999;88:1205-1212
 
2) Grewal, J et al:Real-time three-dimensional transesophageal echocardiography in the intraoperative assessment of mitral valve disease. J Am Soc Echocardiogr 2009;22:34-41
 
P.147 掲載の参考文献
1) Bolling, SF et al:Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381-386
 
2) Kubota, K et al:Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation:importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. J Thorac Cardiovasc Surg 2010;140:617-623
 
3) Rama, A et al:Papillary muscle approximation for functional ischemic mitral regurgitation. Ann Thorac Surg 2007;84:2130-2131
 
P.153 掲載の参考文献
1) Rogers, JH et al:The tricuspid valve:current perspective and evolving management of tricuspid regurgitation. Circulation 2009;119:2718-2725
 
2) Matsunaga, A et al:Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation 2005;112(9 suppl):I453-I457
 
3) Sagie, A et al:Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure:Doppler color flow study of 109 patients. J Am Coll Cardiol 1994;24:446-453
 
4) Fukuda, S et al:Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation. Circulation 2006;114(1 Suppl):I492-I498
 
5) Ton-Nu, T-T et al:Geometric determinants of functional tricuspid regurgitation:insights from 3-dimensional echocardiography. Circulation 2006;114:143-149
 
6) Shiran, A et al:Tricuspid regurgitation in mitral valve disease:incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 2009;53:401-408
 
7) Nath, J et al:Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405-409
 
8) Fukuda, S et al:Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation 2006;114:I-582-I-587
 
9) Sadeghi, HM et al:Does lowing pulmonary arterial pressure eliminate severe functional tricuspid regurgitation? J Am Coll Cardiol 2004;44:126-132
 
10) Mutlak, D et al:Functional tricuspid regurgitation in patients with pulmonary hypertension:is pulmonary artery pressure the only determinant of regurgitation severity? Chest 2009;135:115-121
 
11) Kim, Y-J et al:Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation 2009;120:1672-1678
 
12) Fukuda, S et al:Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation 2005;111:975-979
 
P.158 掲載の参考文献
1) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
2) 松田 暉ほか:弁膜疾患の非薬物治療に関するガイドライン(2007年改訂版), 循環器病の診断と治療に関するガイドライン(2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_matsuda_h.pdf(2011年8月閲覧)
 
3) Dreyfus, GD et al:Secondary tricuspid regurgitation or dilatation:which should be the criteria for surgical repair? Ann Thorac Surg 2005;79:127-132
 
4) Bianchi, G et al:Which patient undergoing mitral valve surgery should also have the tricuspid repair? Interact Cardiovasc Thorac Surg 2009;9:1009-1020
 
5) McCarthy, PM et al:Tricuspid valve repair:Durability and risk factors for failure. J Thorac Cardiovasc Surg 2004;127:674-685
 
6) Tang, GL et al:Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 2006;114:577-581
 
7) Jouan, J et al:Further information from a sonometric study of the normal tricuspid valve annulus in sheep:geometric changes during the cardiac cycle. J Heart Valve Dis 2007;16:511-518
 
8) Izutani, H et al:Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation. Heart International 2010;5:64-68
 
9) Izutani, H et al:Beating-heart tricuspid annuloplasty using the Tailor Flexible Ring. Asian Cardiovasc Thorac Ann 2010;18:489-490
 
10) Fukuda, S et al:Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation 2006;114:I582-I587
 
P.164 掲載の参考文献
1) Mylonakis, E et al:Infective endocarditis in adults. N Engl J Med 2001;345:1318-1330
 
2) Durack, DT et al:New criteria for diagnosis of infective endocarditis:utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96:200-209
 
3) Li, JS et al:Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638
 
4) Horstkotte, D et al:Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary:The task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 2004;25:267-276
 
5) Baddour, LM et al:Infective endocarditis:diagnosis, antimicrobial therapy, and management of complications:a statement for healthcare professionals from the committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association;endorsed by the Infectious Disease Society of America. Circulation 2005;111:e394-e434
 
6) Nakatani, S et al:Current characteristics in infective endocarditis in Japan:an analysis of 848 cases in 2000 and 2001. Circ J 2003;67:901-905
 
7) Cabell, CH et al:The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001;142:75-80
 
8) Thuny, F et al:Risk of embolism and death in infective endocarditis:prognostic value of echocardiography. Circulation 2005;112:744-754
 
9) Heiro, M et al:Neurologic manifestations of infective endocarditis:a 17 year experience in a teaching hospital in Finland. Arch Intern Med 2000;160:2781-2787
 
10) Fabri, J Jr et al:Time-related distribution, risk factors and prognostic influence of embolism in patients with left-sided infective endocarditis. Int J Cardiol 2006;110:334-339
 
11) Piper, C et al:Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001;10:703-711
 
12) Vilacosta, I et al:Risk of embolism after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39;1489-1495
 
13) Feringa, HH et al:Mitral valve repair and replacement in endocarditis:A systematic review of literature. Ann Thorac Surg 2007;83:564-570
 
14) San Roman, JA et al:Clinical course, microbiologic profile, and diagnosis of periannular complications in prosthetic valve endocarditis. Am J Cardiol 1999;83:1075-1079
 
15) Graupner, C et al:Periannular extension of infective endocarditis. J Am Coll Cardiol 2002;39:1204-1211
 
16) Anguera, I et al:Periannular complications in infective endocarditis involving prosthetic aortic valves. Am J Cardiol 2006;98:1261-1268
 
17) Anguera, I et al:Aorto-cavitary fistulous tract formation in infective endocarditis:clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J 2005;26:288-297
 
18) Hill, EE et al:Evolving trends in infective endocarditis. Clin Microbiol Infect 2006;12:5-12
PubMed
19) Eishi, K et al:Surgical management of infective endocarditis associated with cerebral complications. multicenter retrospective study in Japan. J Thorac Cardiovasc Surg 1995;110:1745-1755
 
20) Wang, A et al:Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007;297:1354-1361
 
21) McGee, DC et al:Preventing complications of central venous catheterization. N Engl J Med 2003;348:1123-1133
 
P.170 掲載の参考文献
1) Middlemost, S et al:A case for early surgery in native left-sided endocarditis complicated by heart failure:results in 203 patients. J Am Coll Cardiol 1991;18:663-667
 
2) 宮武邦夫ほか:感染性心内膜炎の予防と治療に関するガイドライン(2008年改訂版), 循環器病の診断と治療に関するガイドライン(2007年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf(2011年8月閲覧)
 
3) Snygg-Martin, U et al:Cerebrovascular complications in patients with left-sided infective endocarditis are common;a progressive study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008;47:23-30
 
4) Baddour, LM et al:Infective endocarditis:diagnosis, antimicrobial therapy, and management of complications. Circulation 2005;111:e394-e433
 
5) Gillinov, AM et al:Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 1996;61:1125-1129
 
6) Eishi, K et al:Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995;110:1745-1755
 
7) Piper, C et al:Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001;10:703-711
 
8) Feringa, HH et al:Mitral valve repair and replacement in endocarditis:a systematic review of literature. Ann Thorac Surg 2007;83:564-570
 
9) Zegdi, R et al:Long-term results of mitral valve repair in active endocarditis. Circulation 2005;111:2532-2536
 
P.172 掲載の参考文献
1) 菊池 賢:感染性心内膜炎の起因菌と治療. 化学療法の領域2003;19:927-932
 
2) Chu, VH et al:Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008;46:232-242
 
3) McDonald, JR:Acute infective endocarditis. Infect Dis Clin North Am 2009;23:643-664
 
4) Que, Y-A et al:Infective endocarditis. Nat Rev Cardiol 2011;8:322-336
 
5) Baddour, LM et al:Infective endocarditis. Diagnosis, antimicrobial therapy, and management of complications. Circulation 2005;111:e394-e433
 
6) Gilbert, DN et al:The Sanford Guide to Antimicrobial Therapy 2011, 41st ed, Antimicrobial Therapy Inc, Sperryville, 2011
 
7) Falagas, ME et al:The role of aminoglycosides in combination with a β-lactam for the treatment of bacterial endocarditis:a meta-analysis of comparative trials. J Antimicrob Chemother 2006;57:639-647
 
8) Leibovici, L et al:Aminoglycoside drugs in clinical practice:an evidence-based approach. J Antimicrob Chemother 2009;63:246-251
 
9) Riedel, DJ:Addition of rifampim to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus. Antimicrob Agents Chemother 2008;52:2463-2467
 
10) Falagas, ME et al:Linezolid for the treatment of patients with endocarditis:a systematic review of the published evidence. J Antimicrob Chemother 2006;58:273-280
 
11) Munoz, P et al:Linezolid therapy for infective endocarditis. Clin Microbiol Infect 2006;13:211-215
 
12) Falagas, ME et al:Daptomycin for endocarditis and/or bacteremia:a systematic review of the experimental and clinical evidence. J Antimicrob Chemother 2007;60:7-19
PubMed
13) Levine, DP:Clinical experience with daptomycin:bacteremia and endocarditis. J Antimicrob Chemother 2008;62(suppl 3):iii35-iii39
 
P.180 掲載の参考文献
1) Masura, J et al:Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder:initial human experience. Cathet Cardiovasc Diagn 1997;42:388-393
 
2) Morton, JB et al:Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect. Circulation 2003;107:1775-1782
 
3) Masutani, S et al:Usefulness of early diastolic mitral annular velocity to predict plasma levels of brain natriuretic peptide and transient heart failure development after device closure of atrial septal defect. Am J Cardiol 2009;104:1732-1736
 
4) Teh, AW et al:Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair. Pacing Clin Electrophysiol 2011;34:431-435
 
P.185 掲載の参考文献
1) Warnes, CA et al:ACC/AHA 2008 guidelines for the management of adults with congenital heart disease:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease):Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e714-e833
 
2) 浜岡建城ほか:先天性心疾患の診断, 病態把握, 治療選択のための検査法の選択ガイドライン, 循環器病の診断と治療に関するガイドライン(2007-2008年度合同研究班報告). Circ J 2009;73(suppl III):1115-1186
 
3) 黒澤博身ほか:成人先天性心疾患診療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2006_kurosawa_h.pdf(2011年8月閲覧)
 
4) Fisher, MR et al:Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179:615-621
 
5) 赤木禎治ほか:成人期の心房中隔欠損症に対するカテーテル治療. 循環器科 2009;66:319-326
 
6) 矢崎 諭ほか:AMPLATZER septal occluder を用いた心房中隔欠損閉鎖術-留置手技に関する考察-. 日小児循環器会誌 2007;23:455-462
 
7) Taniguchi, M et al:Transcatheter closure of atrial septal defect in elderly patients with permanent atrial fibrillation. Catheter Cardiovasc Interv 2009;73:682-686
 
8) Horvath, KA et al:Surgical treatment of adult atrial septal defect:early and long-term results. J Am Coll Cardiol 1992;20:1156-1159
 
9) Konstantinides, S et al:A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 1995;333:469-473
 
10) Murphy, JG et al:Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990;323:1645-1650
 
P.189 掲載の参考文献
1) Vida, VL et al:Minimally invasive operation for congenital heart disease:a sex-differentiated approach. J Thorac Cardiovasc Surg 2009;138:933-936
 
2) Warden, HE et al:An alternative method for repair of partial anomalous pulmonary venous connection to the superior vena cava. Ann Thorac Surg 1984;38:601-605
 
3) DeLeon, SY et al:Surgical techniques in partial anomalous pulmonary veins to the superior vena cava. Ann Thorac Surg 1993;55:1222-1226
 
4) Alanbaei, M et al:Iatrogenic cyanosis and clubbing:25years of chronic hypoxia after the repair of an atrial septal defect. Can J Cardiol 2007;23:901-903
 
5) Chauvin, M et al:The anatomic basis of connections between the coronary sinus musculature and the left atrium in humans. Circulation 2000;101:647-652
 
P.191 掲載の参考文献
1) Jategaonkar, S et al:Percutaneous closure of atrial septal defects:echocardiographic and functional results in patients older than 60 years. Circ Cardiovasc Interv 2009;2:85-89
 
2) Khan, AA et al:The impact of transcatheter atrial septal defect closure in the older population:a prospective study. JACC Cardiovasc Interv 2010;3:276-281
 
3) Taniguchi, M et al:Transcatheter closure of atrial septal defect in elderly patients with permanent atrial fibrillation. Catheter Cardiovasc Interv 2009;73:682-686
 
4) Hirabayashi, A et al:Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension. Catheter Cardiovasc Interv 2009;73:688-691
 
P.195 掲載の参考文献
1) Becker, AE et al:Atrioventricular septal defects:What's in a name? J Thorac Cardiovasc Surg 1982;83:461-469
 
2) Kouchoukos, NT et al:Kirklin/Barratt-Boyes Cardiac Surgery, 3rd ed., Churchill Livingstone, Philadelphia, 2003, 800-849
 
3) Rastelli, G et al:Anatomic observations on complete form of persistent common atrioventricular canal with special reference to atrioventricular valves. Mayo Clin Proc 1966;41:296-308
 
4) Somerville, J:Ostium primum atrial septal defect:factors causing deterioration in natural history. Br Heart J 1965;27:413-417
 
5) Fixler, DE:Atrioventricular septal defect. Surgery of Congenital Heart Disease, Pediatric Cardiac Care Consortium, Perspecteives in Pediatric Cardiology, Moller, JH ed, vol. 6, Futura, Armonk, NY, 1998, 67-83
 
6) Kobayashi, M et al:Deal timing of surgical repair of isolated complete atrioventricular septal defect. Interact Cardiovasc Thorac Surg 2007;6:24-26
 
7) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008. Annual report by The Japanese Association for Thoracic Surgery. Committee for Scientific Affairs. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
P.200 掲載の参考文献
1) Jacobs, JP et al:Congenital Heart Surgery Nomenclature and Database Project:atrioventricular canal defect. Ann Thorac Surg 2000;69(4 Suppl):S36-S43
 
2) Becker, AE et al:Atrioventricular septal defects:What's in a name? J Thorac Cardiovasc Surg 1982;83:461-469
 
3) Backer, CL et al:Atrioventricular canal defects. Pediatric Cardiac Surgery, 3rd ed, Mosby, Philadelphia, 2004, 321-338
 
4) Yamaki, S et al:Pulmonary vascular disease and operative indications in complete atrioventricular canal defect in early infancy. J Thorac Cardiovasc Surg 1993;106:398-405
 
5) Najm, HK et al:Complete atrioventricular septal defects:results of repair, risk factors, and freedom from reoperation. Circulation 1997;96(9 suppl):II-311-II-315
 
6) Kawashima, Y et al:Surgical treatment of complete atrioventricular canal defect with an endocardial cushion prosthesis. Circulation 1983;68(3 Pt 2):II139-II143
 
7) Backer, CL et al:Repair of complete atrioventricular canal defects:results with the two-patch technique. Ann Thorac Surg 1995;60:530-537
 
8) Alexi-Meskishvili, V et al:Correction of complete atrioventricular septal defects with the double-patch technique and cleft closure. Ann Thorac Surg 1996;62:519-524;discussion 524-525
 
9) Nicholson, IA et al:Simplified single patch technique for the repair of atrioventricular septal defect. J Thorac Cardiovasc Surg 1999;118:642-646
 
10) 森田紀代造:房室中隔欠損症(心内膜床欠損症), 心臓外科, 新井達太編, 医学書院, 東京, 2005
 
11) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008;Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
12) Reddy, VM et al:Atrioventricular valve function after single patch repair of complete atrioventricular septal defect in infancy:how early should repair be attempted? J Thorac Cardiovasc Surg 1998;115:1032-1040
 
13) Carpentier, A:Surgical anatomy and management of the mitral component of atrioventricular canal defects. Pediatric Cardiology, Anderson, RH et al eds, Churchill Livingstone, London, 1978, 477
 
14) Masuda, M et al:Does Down syndrome affect the long-term results of complete atrioventricular septal defect when the defect is repaired during the first year of life? Eur J Cardiothorac Surg 2005;27:405-409
 
15) Nakano, T et al:Surgical results of double-orifice left atrioventricular valve associated with atrioventricular septal defects. Ann Thorac Surg 2002;73:69-75
 
P.205 掲載の参考文献
1) McDaniel, NL et al:Ventricular septal defects. Moss and Adams' Heart Disease in Infants, Children and Adolescents, Lippincott Williams & Wilkins, 2008, 667-681
 
2) Scully, BB et al:Current expectations for surgical repair of isolated ventricular septal defects. Ann Thorac Surg 2010;89:544-551
 
3) Tomita, H et al:Severity indices of right coronary cusp prolapse and aortic regurgitation complicating ventricular septal defect in the outlet septumwhich defect should be closed-. Circ J 2004;68:139-143
 
4) 菊地由美ほか:大動脈弁逸脱を伴った膜様部心室中隔欠損について-心エコー図による長期経過観察-. 倉敷中病年報 2001;64:145-147
 
5) Tomita, H et al:Impact of noncoronary cusp prolapse in addition to right coronary cusp prolapse in patients with a perimembranous ventricular septal defect. Int J Cardiol 2005;101:279-283
 
6) Marshall, HW et al:Effect of breathing oxygen on pulmonary artery pressure and pulmonary vascular resistance in patients with ventricular septal defect. Circulation 1961;23:241-252
 
7) Atz, AM et al:Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol 1999;33:813-819
 
8) Ades, AM et al:Morbidity and mortality after surgery for congenital cardiac disease in the infant born with low weight. Cardiol Young 2010;20:8-17
 
9) Curzon, CL et al:Cardiac surgery in infants with low birth weight is associated with increased mortality:analysis of the Society of Thoracic Surgeons Congenital Heart Database. J Thorac Cardiovasc Surg 2008;135:546-551
 
10) Azakie, A et al:Cardiac surgery in low birth weight infants:current outcomes. Interacive Cardiovasc Thorac Surg 2010;12:409-414
 
P.210 掲載の参考文献
1) Soto, B et al:Classification of ventricular septal defects. Br Heart J 1980;43:332-343
 
2) 坂本喜三郎:心室中隔欠損症. 心臓血管外科手術書, 小柳 仁ほか編, 先端医療技術研究所, 東京, 2002, 37-46
 
3) Scully, BB et al:Current expectations for surgical repair of isolated ventricular septal defects. Ann Thorac Surg 2010;89:544-551
 
4) Reddy, V et al:Result of 102 cases complete repair of congenital heart defects in patients weighting 700 to 2500 grams. J Thorac Cardiovasc Surg 1999;117:324-331
 
5) Bove, T et al:Outcome analysis of major cardiac operations in low weight neonates. Ann Thorac Surg 2004;78:181-187
 
6) Christopher, L et al:Cardiac surgery in infants with low birth weight is associated with increased mortality:analysis of the society of thoracic surgeons congenital heart database. J Thorac Cardiovasc Surg 2008;135:546-551
 
P.214 掲載の参考文献
1) Anderson, RH et al:Surgical anatomy of tetralogy of Fallot. J Thorac Cardiovascular Surg 1981;81:887-896
 
2) Ruzmetov, M et al:Repair of tetralogy of Fallot with anomalous coronary arteries coursing across the obstructed right ventricular outflow tract. Pediatr Cardiol 2005;26:537-542
 
3) Samanek, M:Children with congenital heart disease. Probability of natural survival. Pediatr Cardiol 1992;13:152-158
 
4) Niwa, K et al:Mortality and risk factors for late deaths in tetralogy of Fallot:the Japanese Nationwide Multicenter Survey. Cardiol Young 2002;12:453-460
 
5) Alexiou, C et al:Outcome after repair of tetralogy of Fallot in the first year of life. Ann Thorac Surg 2001;71:494-500
 
6) Hirsch, JC et al:Complete repair of tetralogy of Fallot in the neonate:results in the modern era. Ann Surg 2000;232:508-514
 
7) Nakata, S et al:A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg 1984;88:610-619
 
8) Boni, L et al:Current strategies in tetralogy of Fallot repair:pulmonary valve sparing and evolution of right ventricle/left ventricle pressures ratio. Euro J Cardiothorac Surg 2009;35:885-890
 
9) d'Udekem, Y et al:Tetralogy of Fallot. Transannular and right ventricular patching equally affect late functional status. Circulation 2000;102:III116-III122
 
10) Yamagishi, M et al:Outflow reconstruction of tetralogy of Fallot using a Gore-Tex valve. Ann Thorac Surg 1993;56:1414-1416
 
P.219 掲載の参考文献
1) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008:annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
2) Al Habib, HF et al:Contemporary patterns of management of tetralogy of Fallot:Data from the Society of Thoracic Surgeons Database. Ann Thorac Surg 2010;90:813-820
 
3) Kurosawa, H et al:Conotruncal repair for tetralogy of Fallot:Midterm results. T Thorac Cardiovasc Surg 1998;115:351-360
 
4) Miyazaki, T et al:Expanded polytetrafluoroethylene valved conduit and patch with bulging sinuses in right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 2007;134:327-332
 
5) Kawashima, Y et al:Ninety consecutive corrective operations for tetralogy of Fallot with or without minimal right ventriculotomy. J Thorac Cardiovasc Surg 1985;90:856-863
PubMed
6) Karl, T et al:Tetralogy of Fallot:favorable outcome of nonneonatal transatrial, transpulmonary repair. Ann Thorac Surg 1992;54:903-907
 
7) Gatzoulis, MA et al:Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot:a multicentre study. Lancet 2000;356:975-981
 
8) Nakazawa, M et al:Arrhythmias late after repair of tetralogy of fallot:a Japanese Multicenter Study. Circ J 2004;68:126-130
 
9) Stewart, RD et al:Tetralogy of Fallot:results of a pulmonary valve-sparing strategy. Ann Thorac Surg 2005;80:1431-1439
 
P.224 掲載の参考文献
1) Krichenko, A et al:Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989;63:877-880
 
2) Akagi, T et al:Coil occlusion of patent ductus arteriosus using detachable coils. Am Heart J 1997;134:583-543
 
3) Magee, AG et al:Transcatheter coil occlusion of the arterial duct:Results of the European Registry. Eur Heart J 2001;22:1817-1821
 
4) Masura, J et al:Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder:immediate and short-term results. J Am Coll Cardiol 1998;31:878-882
 
5) Pass, RH et al:Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial. Initial and one-year results. J Am Coll Cardiol 2004;44:513-519
 
6) Akagi, T et al:Simultaneous double or triple coil technique for closure of moderate sized(>3.0 mm) patent ductus arteriosus. J Interven Cardiol 2001;14:91-96
 
7) Tomita, H et al:Transcatheter occlusion of patent ductus arteriosus using a 0.052-inch coil:immediate results. Circ J 2000;64:520-523
 
8) Moore, JW et al:Interventional treatment of patent ductus arteriosus in 2004. Cathet Cardiovasc Intervent 2005;64:91-101
 
P.228 掲載の参考文献
1) Gross, RE et al:Surgical ligation of a patent ductus arteriosus. Report of first successful case. JAMA 1939;112:729-731
 
2) Porstmann, W et al:Closure of the persistent ductus arteriosus without thoracotomy. Ger Med Mon 1967;12:259-261
 
3) Rashkind, WJ et al:Transcatheter closure of patent ductus arteriosus;successful use in a 3.5-kilogram infant. Pediatr Cardiol 1979;1:3
 
4) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008:annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
5) Yasuda, K et al:Thoracic and cardiovascular surgery in Japan during 1998:annual report by The Japanese Association for Thoracic Surgery. Jpn J Thorac Cardiovasc Surg 2000;48:401-415
 
6) Hillman, N et al:Patent ductus arteriosus. Pediatric Cardiac Surgery, Mavroudis, C et al eds, Mosby Inc., Philadelphia, 2003, 223-233
 
7) Patent ductus arteriosus. Kirklin/Barratt-Boyes Cardiac Surgery, 3rd ed, Kouchoukos, NT et al eds, Elsevier Science, Salt Lake City, 2003, 928-945
 
8) Stark, J et al:Persistent ductus arteriosus. Surgery for Congenital Heart Defects, 3rd ed, John Wiley & Sons, Ltd., West Sussex, 2006, 275-283
 
9) Kurisu, K:Patent ductus arteriosus. Cardiovascular Surgery for Congenital Heart Disease, Springer, Tokyo, 2009, 25-29
 
10) 豊島勝昭:胎児・新生児の循環. 周産期医2006;36:416-418
 
11) Yokoyama, U et al:Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenyl cyclases in the ductus arteriosus. Circ Res 2010;106:1882-1892
 
12) Laborde, F et al:A new video-assisted thoracoscopic surgical technique for interruption of patent ductus arteriosus in infants and children. J Thorac Cardiovasc Surg 1993;105:278-280
 
P.230 掲載の参考文献
1) Krichenko, A et al:Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneus catheter occlusion. Am J Cardiol 1989;63:877-880
 
2) Magee, AG et al:Transcatheter coil occlusion of the arterial duct;results of the European Registry. Eur Heart J 2001;22:1817-1821
 
3) Pass, RH et al:Multicenter USA Amplatzer patent ductus arteriosus occlussion device trial:Initial and one-year results. J Am Coll Cardiol 2004;44:513-519
 
P.234 掲載の参考文献
1) Celermajer, D et al:Ebstein's anomaly:Presentation and outcome from fetus to adult. J Am Coll Cardiol 1994;23:170-176
 
2) McElhinney, DB et al:Improving outcomes in fetuses and neonates with congenital displacement (Ebstein's malformation)or dysplasia of the tricuspid valve. Am J Cardiol 2005;96:582-586
 
3) Pavlova, M et al:Factors affecting the prognosis of Ebstein's anomaly during fetal life. Am Heart J 1998;135:1081-1085
 
4) Hsieh, YY et al:Successful prenatal digoxin therapy for Ebstein's anomaly with hydrops fetalis. A case report. J Reprod Med 1998;43:710-712
 
5) Sliwa, J et al:Ebstein's malformation in fetus with cardiomegaly. To treat or to observe? A case report. Ginekol Pol 2010;81:135-139
PubMed
6) Yetman, A et al:Outcome of cyanotic neonates with Ebstein's anomaly. Am J Cardiol 1998;81:749-754
 
7) Knott-Craig, CJ et al:Management of neonatal Ebstein's anomaly. Semin Thorac Surg Pedatr Card Surg Ann 2007;10:112-116
 
8) Bove, EL et al:How I manage neonatal Ebstein's anomaly. Semin Thorac Surg Pedatr Card Surg Ann 2009;12:63-65
 
9) Starnes, VA et al:Ebstein's anomaly appearing in the neonate. J Thorac Cardiovasc Surg 1991;101:1082-1087
 
10) Bartlett, HL et al:Early outcomes of tricuspid valve replacement in young children. Circulation 2007;115:319-325
 
11) Brown, ML et al:Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly. Am J Cardiol 2009;103:555-561
 
12) Badiu, CC et al:Early timing of surgical intervention in patients with Ebstein's anomaly predicts superor long-term outcome. Eur J Cardiothorac Surg 2010;37:186-192
 
13) Connoly, HM et al:Ebstein's anomaly:outcome of pregnancy. J Am Coll Cardiol 1994;23:1194-1198
 
P.238 掲載の参考文献
1) Knott-Craig, CJ et al:Repair of Ebstein's anomaly in the symptomatic neonate:an evolution of technique with 7-year follow up. Ann Thorac Surg 2002;73:1786-1793
 
2) Da Silva, JP et al:The cone reconstruction of the tricuspid valve in Ebstein's anomaly. The operation:early and mid term results. J Thorac Cardiovasc Surg 2007;133:215-223
 
3) Starnes, VA et al:Ebstein's anomaly appearing in the neonate:a new surgical approach. J Thorac Cardiovasc Surg 1991;101:1082-1087
 
4) Badiu, CC et al:Early timing of surgical intervention in patients with Ebstein's anomaly predicts superior long-term outcome. Eur J Cardiothorac Surg 2010;37:186-192
 
5) Boston, US et al:Tricuspid valve repair for Ebstein's anomaly in young children:a 30-year experience. Ann Thorac Surg 2006;81:690-695, discussion 695-696
 
6) Link, KM et al:MR imaging of Ebstein anomaly:results in four cases. Am J Roentgenol 1988;150:363-367
 
7) Carpentier, A et al:A new reconstructive operation for Ebstein's anomaly of the tricuspid valve. J Thorac Cardiovasc Surg 1988;96:92-101
 
8) Hetzer, R et al:A modified repair technique for tricuspid incompetence in Ebstein's anomaly. J Thorac Cardiovasc Surg 1998;115:857-868
 
9) Schreiber, C et al:Morphologic spectrum of Ebstein's malformation:revis1itation relative to surgical repair. J Thorac Cardiovasc Surg 1999;117:148-155
 
10) Marianeschi, SM et al:Alternative approach to the repair of Ebstein's malformation:Intra cardiac repair with ventricular unloading. Ann Thorac Surg 1998;66:1546-1550
 
P.242 掲載の参考文献
1) Fontan, F et al:Surgical repair of tricuspid atresia. Thorax 1971;26:240-248
 
2) Glenn, WW:Circulatory bypass of the right side of the heart. N Engl J Med 1958;259:117-120
 
3) Choussat, A et al:Selection criteria for Fontan's procedure. Pediatric Cardiology, Anderson, RH et al eds, Churchill Livingstone, Edinburgh, 1978, 559-566
 
4) Azzolina, G et al:Tricuspid atresia. Thorax 1972;27:111-115
 
5) Bjork, VO et al:Right atrial-right ventricular anastomosis for correction of tricuspid atresia. J Thorac Cardiovasc Surg 1979;77:452-458
 
6) de Leval, MR et al:Total cavopulmonary connection. J Thorac Cardiovasc Surg 1988;96:682-695
 
7) Marcelletti, C et al:Inferior vena cava-pulmonary artery extracardiac conduit. J Thorac Cardiovasc Surg 1990;100:228-232
 
P.247 掲載の参考文献
1) Fontan, F et al:Surgical repair of tricuspid atresia. Thorax 1971;26:240-248
 
2) de Leval, M et al:Total cavopulmonary connection. A logical alternative to atriopulmonary connection for complex Fontan operations. J Thorac Cardiovasc Surg 1988;96:682-695
 
3) Bridges, N et al:Bidirectional cavopulmonary anastomosis as interim palliation for high-risk Fontan candidates. Early results. Circulation 1990;82(suppl 4):170-176
 
4) Marcelletti, C et al:Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg 1990;100:228-232
 
5) Fujii, Y et al:Midterm to long-term outcome of total cavopulmonary connection in high-risk adult candidates. Ann Thorac Surg 2009;87:562-570
 
6) Gentles, TL et al:Fontan operation in five hundred consecutive children:factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997;114:376-391
 
7) Kirklin, JK et al:Is the "Perfect Fontan"operation routinely achievable in the modern era? Cardiol Young 2008;18:328-336
 
8) Fujii, Y et al:Double-barrel Damus-Kaye-Stansel operation is better than end-to-side Damus-Kaye-Stansel operation for preserving the pulmonary valve function:The importance of preserving the shape of the pulmonary sinus. J Thorac Cardiovasc Surg 2011;141:193-199
 
9) Kotani, Y et al:Clinical outcome of the Fontan operation in patients with impaired ventricular function. Eur J Cardiothorac Surg 2009;36:683-687
 
10) Nakata, S et al:A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart disease with decreased pulmonary blood flow. J Thorac Cardiovasc Surg 1984;88:610-619
 
11) Azakie, A et al:Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution:impact on outcomes. J Thorac Cardiovasc Surg 2001;122:1219-1228
 
12) Morales, DLS et al:Salvaging the failing Fontan:lateral tunnel versus extracardiac conduit. Ann Thorac Surg 2005;80:1445-1452
 
13) Bridges, ND et al:Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation 1992;86:1762-1769
 
14) Hsia, TY et al:Effect of fenestration on the sub-diaphragmatic venous hemodynamics in the total-cavopulmonary connection. Eur J Cardiothorac Surg 2001;19:785-792
 
P.250 掲載の参考文献
1) Khairy, P et al:Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008;117:85-92
PubMed
2) 先崎秀明:Fontan 術後の心機能. Annual Review 循環器, 中外医学社, 東京, 2007, 271-277
 
3) Senzaki, H et al:Reconsideration of criteria for the Fontan operation. Influence of pulmonary artery size on postoperative hemodynamics of the Fontan operation. Circulation 1994;89:266-271
 
4) Senzaki, H et al:Ventricular afterload and ventricular work in Fontan circulation:comparison with normal two-ventricle circulation and single-ventricle circulation with Blalock-Taussig shunts. Circulation 2002;105:2885-2892
 
5) Senzaki, H et al:Cardiac rest and reserve function in patients with Fontan circulation. J Am Coll Cardiol 2006;47:2528-2535
 
P.254 掲載の参考文献
1) 横山晋二ほか:EBMに基づく川崎病後遺症へのカテーテル治療:急性期成績と長期予後. EBM小児疾患の治療, 五十嵐 隆ほか編, 中外医学社, 東京, 2011, 158-162
 
2) Ishii, M et al:Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease:Quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002;105:3004-3010
 
3) Ishii, M et al:Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatri Int 2001;43:558-562
 
4) 森重徳継ほか:冠動脈バイパス術. 川崎病のすべて, 小児科臨床ピクシス, 石井正浩ほか編, 中山書店, 東京, 2009, 60-61
 
5) Muta, H et al:Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. J Pediatr 2010;157:120-126
 
P.258 掲載の参考文献
1) Kawasaki, T:Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. [in Japanese]. Arerugi 1967;16:178-222
 
2) Newburger, JW et al:Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 2004;110:2747-2771
 
3) Senzaki, H:Long-term outcome of Kawasaki disease. Circulation 2008;118:2763-2772
 
4) Wood, LE et al:Kawasaki disease in children. Heart 2009;95:787-792
 
5) Akagi T:Interventions in Kawasaki disease. Pediatr Cardiol 2005;26:206-212
 
6) Tsuda, E et al:Percutaneous transluminal coronary rotational atherectomy for localized stenosis caused by Kawasaki disease. Pediatr Cardiol 2006;27:447-453
 
7) Ishii, M et al:Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease. Quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002;105:3004-3010
 
8) Kitamura, S et al:Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation 2009;120:60-68
 
9) Ishii, M et al:Guideline for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int 2001;43:558-562
 
10) JCS joint working group:Guideline for diagnosis and management of cardiovascular sequelae in Kawasaki disease(JCS 2008). Digest version. Circ J 2010;74:1989-2020
 
11) Tsuda, E et al, The cooperative study group of Japan:National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 204;110:II-61-II-66
 
12) Muta, H et al:Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. J Pediatr 2010;157:120-126
 
13) Yamauchi, H et al:Optima time of surgical treatment for Kawasaki coronary artery disease. J Nippon Med Sch 2004;71:279-286
 
14) Tsuda, E et al:Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease. Comparison of early with recent results in small children. Am Heart J 2007;153:995-1000
 
15) Newburger, JW et al:Coronary revascularization in patients with Kawasaki disease. J Pediatr 2010;157:8-10
 
16) Masuda, M et al:Late results after mitral valve replacement with bileaflet mechanical prosthesis in children. Evaluation of prosthesis-patient mismatch. Ann Thorac Surg 2004;77:913-917
 
P.262 掲載の参考文献
1) Niwa, K et al:Mortality and risk factors for late deaths in tetralogy of Fallot:the Japanese Nationwide Multicenter Survey. Cardiol Young 2002;12:453-460
 
2) Gatzoulis, MA et al:Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot:a multicenter study. Lancet 2000;356:975-981
 
3) Oechslin, EN et al:Reoperation in adults with repair of tetralogy of Fallot:indications and outcomes. J Thorac Cardiovasc Surg 1999;118:245-251
 
4) Therrien, J et al:Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001;103:2489-2494
 
5) Momenah, TS et al:Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009;53:1859-1863
 
6) van Straten, A et al:Right ventricular function late after total repair of tetralogy of Fallot. Eur Radiol 2005;15:702-707
 
7) Therrien, J et al:Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005;95:779-782
 
8) Therrien, J et al:Pulmonary valve replacement in adults late after repair of tetralogy of Fallot. Are we operating too late? J Am Coll Cardiol 2000;36:1670-1675
 
9) Warnes, CA et al:ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008;118:2329-2431
 
10) Geva, T:Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006;9:11-22
 
P.266 掲載の参考文献
1) Davlouros, PA et al:Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol 2004;97:91-101
 
2) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
3) Oechslin, EN et al:Reoperation in adults with repair of tetralogy of Fallot:indications and outcomes. J Thorac Cardiovasc Surg 1999;118:245-251
 
4) Meijboom, FJ et al:Consequences of a selective approach toward pulmonary valve replacement in adult patients with tetralogy of Fallot and pulmonary regurgitation. J Thorac Cardiovasc Surg 2008;135:50-55
 
5) Discigil, B et al:Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001;121:344-351
 
6) Therrien, J et al:Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005;95:779-782
 
7) Miyazaki, T et al:Expanded polytetrafluoroethylene valved conduit and patch with bulging sinuses in right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 2007;134:327-332
 
P.269 掲載の参考文献
1) Andersen, HR et al:Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-708
 
2) Bonhoeffer, P et al:Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403-1405
 
3) Zahn, EM et al:Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol 2009;54:1722-1729
 
4) McElhinney, DB et al:Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122:507-516
 
5) Boone, RH et al:Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv 2010;75:286-294
 
P.277 掲載の参考文献
1) 高本眞一ほか:大動脈瘤・大動脈解離診療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). Circ J 2006;70(suppl IV):1569-1646
 
2) Kaji, S et al:Prediction of progression or regression of type A aortic intramural hematoma by computed tomography. Circulation 1999;100:II-281-II-286
 
3) Song, JM et al:Usefulness of the initial noninvasive imaging study to predict the adverse outcomes in the medical treatment of acute type A aortic intramural hematoma. Circulation 2003;108:II324-II328
 
4) Suzuki, T et al:Clinical profiles and outcomes of acute type B aortic dissection in the current era:lessons from the International Registry of Aortic Dissection(IRAD). Circulation 2003;108(suppl 1):II312-II317
 
5) Mehta, RH et al:Acute type A aortic dissection in the elderly:clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol 2002;40:685-692
 
6) Davies, RR et al:Thoracic Surgery Directors Assocoation Award. What is the optimal management of late-presenting survivors of acute type A aortic dissection? Ann Thorac Surg 2007;83:1593-1602
 
7) Gillinov, AM et al:Dissection of the ascending aorta after previous cardiac surgery:differences in presentation and management. J Thorac Cardiovasc Surg 1999;117:252-260
 
8) Erbel, R et al:Diagnosis and management of aortic dissection:Task Force on Aortic Dissection, European Society of Cardiology. Eur Heart J 2001;22:1642-1681
 
9) Cardiac tamponade complicating proximal aortic dissection. Is pericardiocentesis harmful? Circulation 1994;90(5):2375-2378
 
10) Tran, TP et al:Current management of type B aortic dissection. Vasc Health Risk Manag 2009;5:53-63
 
11) Kodama, K et al:Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation 2008;118:167-170
 
12) Yang, J et al:Endovascular stent-graft treatment of thoracic aortic dissection. Interact Cardiovasc Thorac Surg 2006;5:688-691
 
13) Shimono, T et al:Transluminal stent-graft placements for the treatments of acute onset and chronic aortic dissections. Circulation 2002;106:I241-I247
 
14) Rubin, S et al:Retrograde aortic dissection after a stent graft repair of a type B dissection:how to improve the endovascular technique. Interact Cardiovasc Thorac Surg 2006;5:746-748
 
15) 石丸 新:治療:ステントグラフトの適応と予後. J Jpn Coll Angiol 2008;48:31-35
 
16) Nienaber, CA et al:Randomized comparison of strategies for type B aortic dissection the investigation of stent grafts in aortic dissection(INSTEAD) trial. Circulation 2009;120:2519-2528
 
P.282 掲載の参考文献
1) De Bakey, ME et al:Surgical considerations of dissecting aneurysm of the aorta. Ann Surg 1955;142:586-610;discussion, 611-612
 
2) Ueda, Y et al:Thoracic and cardiovascular surgery in Japan during 2007. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2009;57:488-513
 
3) Borst, HG et al:Type A aortic dissection:diagnosis and management of malperfusion phenomena. Semin Thorac Cardiovasc Surg 1991;3:238-241
 
4) Okita, Y et al:Surgical strategies in managing organ malperfusion as a complication of aortic dissection. Eur J Cardiothorac Surg 1995;9:242-246
 
5) Munakata, H et al:Controlled earlier reperfusion for brain ischemia caused by acute type A aortic dissection. Ann Thorac Surg 2009;87:e27-e28
 
6) Hiratzka, LF et al:2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease:A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010;121:e266-e369
 
7) Elefteriades, JA:Indication for aortic replacement. J Thorac Cardiovasc Surg 2010;140(6 suppl):S5-S9;discussion S45-S51
 
P.284 掲載の参考文献
1) Leber, AW et al:Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography. A comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005;46:147-154
 
P.286 掲載の参考文献
1) Nienaber, CA et al:Aortic dissection:new frontiers in diagnosis and management:Part II:therapeutic management and follow-up. Circulation 2003;108:772-778
 
2) 高本眞一ほか:大動脈瘤・大動脈解離診療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). Circ J 2006;70(suppl IV):1569-1646
 
3) Kato, M et al:Determining surgical indications for acute type B dissection based on enlargement of aortic diameter during the chronic phase. Circulation 1995;92:II107-II112
 
4) Deeb, GM et al:Surgical delay for acute type A dissection with malperfusion. Ann Thorac Surg 1997;64:1669-1675
 
P.290 掲載の参考文献
1) Powell, JT et al:Clinical practice. Small abdominal aortic aneurysms. N Engl J Med 2003;348:1895-1901
 
2) Norman, PE et al:Abdominal aortic aneurysm, The prognosis in women is worse than in men. Circulation 2007;115:2865-2869
 
3) 知久正明ほか:大動脈瘤:内科. 新・心臓病診療プラクティス2 心疾患の手術適応と至適時期, 赤阪隆史ほか編, 文光堂, 東京, 2004, 270-274
 
4) 高本眞一ほか:大動脈瘤・大動脈解離診療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). Circ J 2006;70(suppl IV):1569-1646
 
5) Brewster, BC et al:Guidelines for the treatment of abdominal aortic aneurysms. J Vasc Surg 2003;37:1106-1117
 
6) Juvonen, T et al:Prospective study of the natural history of thoracic aortic aneurysms. Ann Thorac Surg 1997;63:1533-1545
 
7) Davies, RR et al:Yearly rupture or dissection rates for thoracic aortic aneurysms:sample prediction based on size. Ann Thorac Surg 2002;73:17-27, discussion 27-28
 
8) Steyerberg, EW et al:Perioperative mortality of elective abdominal aortic aneurysm surgery. Arch Intern Med 1995;155:1998-2004
 
P.295 掲載の参考文献
1) Davies, RR et al:Yearly rupture or dissection rates for thoracic aortic aneurysms:simple precliction based on size. Ann Thorac Surg 2002;73:17-28
 
2) Brewster. DC et al:Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 2003;37:1106-1117
 
3) Powll, JT et al:Cilnical practice. Small abdominal aortic aneurysms. N Engl J Med 2003;348:1895-1901
 
4) 高本眞一ほか:大動脈瘤・大動脈解離診療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). Circ J 2006;70(suppl IV):1569-1646
 
5) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
P.297 掲載の参考文献
1) Greenhalgh, RM et al:Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010;362:1863-1871
 
2) Younes, HK et al:Hybrid thoracic endovascular aortic repair:pushing the envelope. J Vasc Surg 2010;51:259-266
 
3) Shimokawa, T et al:Outcome of surgical treatment in patients with acute type B aortic dissection. Ann Thorac Surg 2008;86:103-107
 
4) Greenberg, R:Branched endografts for thoracoabdominal aneurysms. J Thorac Cardiovasc Surg 2010;140:S171-S178
 
5) Nienaber, CA et al:Randomized comparison of strategies for type B aortic dissection:the INvestigation of STEnt Grafts in Aortic Dissection(INSTEAD) trial. Circulation 2009;120:2519-2528
 
P.299 掲載の参考文献
1) Joyce, JW et al:Aneurysm of the thoracic aorta:a clinical study with special reference to prognosis. Circulation 1964;29:176-181
 
2) Elefteriades, JA:Natural history of thoracic aortic aneurysm:indication for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002;74:S1877-S1880
 
3) 雨宮邦子ほか:大動脈瘤の経時的発育と自然予後. カレントテラピー1996;14:13-19
 
4) Achenbach, S et al:Detection of coronary artery stenosis by low-dose, prospectively ECG-triggered, high-pitch spiral coronary CT angiography. JACC Cardiovasc Imaging 2011;4:328-337
 
P.308 掲載の参考文献
1) Hirsch, AT et al:ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease(lower extremity, renal, mesenteric, and abdominal aortic):A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease):Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation;National Heart, Lung, and Blood Institute;Society for Vascular Nursing;TransAtlantic Inter-Society Consensus;and Vascular Disease Foundation. Circulation 2006;113:e463-e654
 
2) Barani, J et al:Cardiac function, inflammatory mediators and mortality in critical limb ischemia. Angiology 2006;57:437-444
 
3) Dormandy, JA et al:Management of peripheral arterial disease(PAD). TASC Working Group. Trans-Atlantic Inter-Society Consensus(TASC). J Vasc Surg 2000;31(1 Pt 2):S1-S296
 
4) Tegtmeyer, CJ et al:Results and complications of angioplasty in aortoiliac disease. Circulation 1991;83(suppl I):I-53-I-60
 
5) Gallino, A et al:Percutaneous transluminal angioplasty of the arteries of the lower limbs:a 5-year follow-up. Circulation 1984;70:619-623
 
6) Johnston, K:Balloon angioplasty:predictive factors for long-term success. Semin Vasc Surg 1989;3:117-122
 
7) Wilson, SE et al:Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trail in a selected group of patients. J Vasc Surg 1989;9:1-9
 
8) Sullivan, TM et al:Percutaneous translumineral angioplasty and primary stenting of the iliac arteries in 288 patients. J Vasc Surg 1997;25:829-838, discussion 838-839
 
9) Ponec, D et al:The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty:CRISP-US trial results. J Vasc Interv Radiol 2004;15:911-918
 
10) Palmaz, JC et al:Stenting of the iliac arteries with the Palmaz stent:experience from a malticenter trial. Cardiovasc Intervent Radiol 1992;15;291-297
 
11) de Vries, SO et al:Intermittent claudication:cost-effectiveness of revascularization versus exercise therapy. Radiology 2002;222:25-36
 
12) Feinglass, J et al:Functional status and walking ability after lower extremity bypass grafting or angioplasty for intermittent claudication:results from a prospective outcomes study. J Vasc Surg 2000;31(1 Pt 1):93-103
PubMed
13) Spronk, S et al:Intermittent claudication:functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty-systematic review. Radiology 2005;235:833-842
 
14) Holm, J et al:Chronic lower limb ischaemia. A prospective randomized controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty(PTA). Eur J Vasc Surg 1991;5:517-522
 
15) Muradin, GS et al:Balloon dilatation and stent implantation for treatment of femoropopliteal arterial disease:meta-analysis. Radiology 2001;221:137-145
 
16) Vroegindeweij, D et al:Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions:A comparative randomized study. Cardovasc Intervent Radiol 1997;20:420-425
 
17) Schillinger, M et al:Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888
 
18) Soga, Y et al:Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol 2009;53:48-53
PubMed
19) Soga, Y et al:Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg 2010;52:608-615
 
20) Adam, DJ et al:Bypass versus angioplasty in severe ischemia of the leg(BASIL):multicenter, randomized controlled trial. Lancet 2005;366:1925-1934
 
P.313 掲載の参考文献
1) Norgren, L et al:Inter-society consensus for the management of peripheral arterial disease(TASC II). J Vasc Surg 2007;45(Suppl S):S5-S67
 
2) Koizumi, A et al:Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J 2009;73:860-866
 
3) Ichihashi, S et al:Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus(TASC)-II. J Vasc Surg 2011;53:992-999
 
4) Chang, RW et al:Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 2008;48:362-367
 
5) Periera, CE et al:Meta-analysis of femoropopliteal bypass graft for lower extremity arterial insufficiency. J Vasc Surg 2006;44:510-517
 
6) Mwipatayi, BP et al:Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease:A meta-analysis. J Vasc Surg 2008;47:461-469
 
7) Iida, O et al:Retrospective multicentre analysis of SMART vs Luminexx nitinol stent implantation for superficial femoral artery lesions(REAL SL)registry. Circ J 2011;75:421-427
 
8) Bradbury, AW:Bypass versus angioplasty in severe ischaemia of the leg(BASIL):multicentre, randomized controlled trial. Lancet 2005;366:1925-1934
 
9) Bradbury, AW et al:Bypass versus angioplasty in severe ischaemia of the leg(BASIL)trial:analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010;51:18s-31s
 
10) Romiti, M et al:Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47:975-981
 
P.315 掲載の参考文献
1) Sasajima, T et al:Combined distal venous arterialization and free flap for patients with extensive tissue loss. Ann Vasc Surg 2010;24:373-381
 
2) Briggs, SE et al:Distal revascularization and microvascular free tissue transfer:An alternative to amputation in ischemic lesions of the lower extremity. J Vasc Surg 1985;2:806-811
 
P.318 掲載の参考文献
1) Rubin, GD et al:Multidetector row CT angiography of lower extremity arterial inflow and runoff:initial experience. Radiology 2001;221:7-10
 
2) Koelemay, MJ et al:Magnetic resonance angiography for the evaluation of lower extremity arterial disease:a-metaanalysis. JAMA 2001;285:1338-1345
 
3) Sadowski, EA et al:Nephrogenic systemic fibrosis:risk factors and incidence estimation. Radiology 2007;243:148-157
 
P.321 掲載の参考文献
1) 松尾 汎:血管エコー診断の概説. Innervision 2003;18:68-74
 
2) TASC II Working Group/日本脈管学会訳:下肢閉塞性動脈硬化症の診断・治療指針II, 日本脈管学会編, メディカルトリビューン社, 東京, 2007, 1-109
 
3) 松尾 汎:血管診療テキスト・脈管診療の現況. Vascular Lab 2010;7(増刊):6-14
 
4) 福島洋行:わかりやすい末梢循環Q&A. Angiology Frontier 2002;1:92-93
 
P.324 掲載の参考文献
1) Pomposelli, FB et al:Lower extremity aneurysms. Rutherford's Vascular Surgery, 7th ed, Saunders, Philadelphia, 2010, 2110-2127
 
2) Haimovici, H:Peripheral arterial aneurysms. Vascular Surgery, Haimovici, H et al eds, Appleton & Lange, Norwalk, 1989, 670-684
 
3) Johnson, ON 3rd et al:Outcomes of surgical management for popliteal artery aneurysms:an analysis of 583 cases. J Vasc Surg 2008;48:845-851
 
4) Timaran, CH:Upper Extremity Aneurysms. Rutherford's Vascular Surgery, 7th ed, Saunders, Philadelphia, 2010, 2128-2139
 
5) Atkins, MD et al:Carotid artery disease:aneurysms. Rutherford's Vascular Surgery, 7th ed, Saunders, Philadelphia, 2010, 1497-1511
 
P.329 掲載の参考文献
1) Norgren, L et al:Inter-Society Consensus for the Management of Peripheral Arterial Disease(TASC II). J Vasc Surg 2007;45(suppl S):S5-67
 
2) Abou-Zamzam, AM Jr et al:A prospective analysis of critical limb ischemia:factors leading to major primary amputation versus revascularization. Ann Vasc Surg 2007;21:458-463
 
3) Isner, JM et al:Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999;103:1231-1236
 
4) Losordo, DW et al:Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I:angiogenic cytokines. Circulation 2004;109:2487-2491
 
5) Tateishi-Yuyama, E et al:Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells:a pilot study and a randomised controlled trial. Lancet 2002;360:427-435
 
6) Huang, P et al:Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005;28:2155-2160
 
7) Moriya, J et al:Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Circ Cardiovasc Interv 2009;2:245-254
 
8) Matoba, S et al:Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells(Therapeutic Angiogenesis by Cell Transplantation[TACT]trial)in patients with chronic limb ischemia. Am Heart J 2008;156:1010-1018
 
P.336 掲載の参考文献
1) Trichon, BH et al:Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-543
 
2) Otsuji, Y et al:Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation:direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997;96:1999-2008
 
3) Otsuji, Y et al:Isolated annular dilation does not usually cause important functional mitral regurgitation:comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol 2002;39:1651-1656
 
4) Lancellotti, P et al:Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 2003;108:1713-1717
 
5) Bonow, RO et al:ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease)developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148
 
6) Murakami, M et al:Mitral valve repair for 52 patients with severe left ventricular dysfunction. Ann Thorac Cardiovasc Surg 2009;15:160-164
 
7) Gummert, JF et al:Mitral valve repair in patients with end stage cardiomyopathy:who benefits? Eur J Cardiothorac Surg 2003;23:1017-1022, discussion 1022
PubMed
8) Wu, AH et al:Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-387
 
9) De Bonis, M et al:Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy. Ann Thorac Surg 2008;85:932-939
 
11) Kanzaki, H et al:A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy:insights from mechanical activation strain mapping. J Am Coll Cardiol 2004;44:1619-1625
 
11) Breithardt, OA et al:Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-770
 
P.340 掲載の参考文献
1) Bolling, S et al:Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995;109:676-682
 
2) Grossi, EA et al:Ischemic mitral valve reconstruction and replacement:Comparison of long-term survival and complications. J Thorac Cardiovasc Surg 2001;122:1107-1124
 
3) Gillinov, AM et al:Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001;122:1125-1141
 
4) Borger, MA et al:Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007;133:1483-1492
 
5) Spoor, MT et al:Flexible versus nonflexible mitral valve rings for congestive heart failure. Differential durability of repair. Circulation 2006;114(suppl I):I-67-I-71
 
6) Magne, J et al:Ischemic mitral regurgitation:A complex multifaceted disease. Cardiology 2009;112:244-259
 
7) Kuwahara, E et al:Mechanism of recurrent/persistent ischemic/ functional mitral regurgitation in the chronic phase after surgical annuloplasty:importance of augmented posterior leaflet tethering. Circulation 2006;114:1529-1534
 
8) Lee, APW et al:Mechanism of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy:importance of distal anterior leaflet tethering. Circulation 2009;119:2606-2614
 
9) De Bonis, M et al:Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy. Role of the "Edge-to-edge" technique. Circulation 2005;112(suppl I):I-402-I-408
 
10) Messas, E et al:Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. Circulation 2003;108(suppl II):II-111-II-115
 
11) Borger, MA et al:Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007;133:1483-1492
 
12) Rodriguez, F et al:Importance of mitral valve second-order chordae for left ventricular geometry, wall thickening mechanics, and global systolic function. Circulation 2004;110(suppl II):II-115-II-122
 
13) Messas, E et al:Relief of mitral leaflet tethering following chronic myocardial infarction by chordal cutting diminishes left ventricular remodeling. Circ Cardiovasc Imaging 2010;3:679-686
 
14) Kron, IL et al:Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 2002;74:600-601
 
15) Ono, M et al:Routine use of bilateral papillary muscle elevation for surgical treatment of functional mitral valve regurgitation in dilated cardiomyopathy. Circ J 2010;74(suppl 1):46
 
16) Nair, RU et al:Left ventricular volume reduction without ventriculectomy. Ann Thorac Surg 2001;71:2046-2049
 
17) Shingu, Y et al:Papillary muscle suspension concomitant with approximation for functional mitral regurgitation. Circ J 2009;73:2061-2067
 
18) Calafiore, AM et al:Mitral valve procedure in dilated cardiomyopathy:Repair or replacement. Ann Thorac Surg 2001;71:1146-1153
 
P.346 掲載の参考文献
1) Jones, RH et al:Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009;360:1705-1717
 
2) Batista, RJV et al:Ventricylectomiaparcial:umnovo conceito no tretento cirurgico de cardiooatias em fase final. Anais do X XII Congresso Nacional de Cirurgia Cardiaca, Brasilia, Soc Brasileira de Cirurgia Cardiaca, 1995, 140-141
 
3) Dor, V et al:Endoventricular patch plasties with septal exclusion for repair of ischemic left ventricle:technique, results and indications from a series of 781 cases. Jpn J Thorac Cardiovasc Surg 1998;46:389-398
 
4) Isomura, T et al:Septal anterior ventricular exclusion operation(Pacopexy)for ischemic dilated cardiomyopathy:treat form not disease. Eur J Cardiothorac Surg 2006;29(suppl 1):S245-S250
PubMed
5) Matsui, Y et al:Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg 2002;124:395-397
 
6) White, HD et al:Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51
 
7) Buckberg, GD et al:The STICH trial:misguided conclusions. J Thorac Cardiovasc Surg 2009;138:1060-1064, e1062
 
8) Matsui, Y et al:Left ventricular reconstruction for severely dilated heart. Ann Thorac Cardiovasc Surg 2008;14:66-74
 
P.353 掲載の参考文献
1) Yamaguchi, A et al:Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg 1998;65:434-438
 
2) Soliman Hamad, MA et al:Long-term results of coronary artery bypass grafting in patients with left ventricular dysfunction. Ann Thorac Surg 2008;85:488-493
 
3) Di Donato, M et al:Intermediate survival and predictors of death after surgical ventricular restoration. Semin Thorac Cardiovasc Surg 2001;13:468-475
 
4) Buckberg, GD et al:The STICH trial:misguided conclusions. J Thorac Cardiovasc Surg 2009;138:1060-1064
 
5) Calafiore, AM et al:Left ventricular surgical restoration for anteroseptal scars:Volume versus shape. J Thorac Cardiovasc Surg 2010;139:1123-1130
 
6) Bolling, SF et al:Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381-388
 
7) Magne, J et al:Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 2008;51:1692-1701
 
8) Braun, J et al:Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008;85:430-437
 
9) Dor, V et al:Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction:comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998;116:50-59
 
10) Di Donato, M et al:Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg 2001;121:91-96
 
11) Isomura, T et al:Septal anterior ventricular exclusion operation(Pacopexy)for ischemic dilated cardiomyopathy:treat form not disease. Eur J Cardiothorac Surg 2006;29:S245-S250
PubMed
12) Matsui, Y et al:Integrated overlapping ventriculoplasty combined with papillary muscle placation for severely dilated heart failure. J Thorac Cardiovasc Surg 2004;127:1221-1223
 
13) Batista, RJ et al:Partial left ventriculectomy to improve left ventricular function. J Card Surg 1996;11:96-97;discussion 98
 
14) Suma, H et al:Selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure:Midterm results and risk analysis. Eur J Cardiothorac Surg 2007;32:912-916
 
15) Menicanti, L et al:Surgical therapy for ischemic heart failure:Single center experience with surgical anterior ventricular restoration. J Thorac Cardiovasc Surg 2007;134:433-441
 
16) Sartipy, U et al:Risk factors for mortality and hospital re-admission after surgical ventricular restoration. Eur J Cardiothorac Surg 2006;30:762-769
 
17) Ueno, T et al:Mid-term changes of left ventricular geometry and function after Dor, SAVE, and Overlapping procedures. Eur J Cardiothorac Surg 2007;32:52-57
 
18) Jones, RH et al:Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009;360:1705-1717
 
19) Buckberg, GD et al:The structure and function of the helical heart and its buttress wrapping. VI. Geometric concepts of heart failure and use for structural correction. Semin Thorac Cardiovasc Surg 2001;13:386-401
 
20) Hunt, SA et al:ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(writing committee to update the 2001 guidelines for the evaluation and management of heart failure):Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:Endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235
 
21) Dor, V et al:Endoventricular patch reconstruction of ischemic failing ventricle:a single center with 20years experience. advantages of magnetic resonance imaging assessment. Heart Fail Rev 2004;9:269-286
 
22) Kim, RJ et al:The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453
 
23) Marui, A et al:Significance of left ventricular diastolic function on outcome after surgical ventricular restoration. Ann Thorac Surg 2010;89:1524-1531
 
24) Skelley, NW et al:The impact of volume reduction on early and long-term outcomes in surgical ventricular restoration for severe heart failure. Ann Thorac Surg 2011;91:104-111;discussion 111-112
 
25) Wu, AH et al:Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-387
 
P.356 掲載の参考文献
1) Levy, D et al:Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1342
 
2) Shah, PJ et al:Survival after myocardial revascularization for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2003;126:1320-1327
 
3) Allman, KC et al:Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:A meta-analysis. J Am Coll Cardiol 2002;39:1151-1158
 
4) Klein, P et al:Early and late outcome of left ventricular reconstruction surgery in ischemic heart disease. Eur J Cardiothorac Surg 2008;34:1149-1157
 
5) Buckberg, GD et al:The STICH trial:Misguided conclusions. J Thorac Cardiovasc Surg 2009;138:1060-1064
 
6) Jones, RH et al:Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009;360:1705-1717
 
P.361 掲載の参考文献
1) Roussel, JC et al:CardioWest(Jarvik)total artificial heart:a single-center experience with 42 patients. Ann Thorac Surg 2009;87:124-130
PubMed
2) Dowling, RD et al:Initial experience with the Abercorn implantable replacement heart system. J Thorac Cardiovasc Surg 2004;127:131-141
 
3) Siegenthaler, MP et al:The Jarvik 2000 is associated with less infection than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg 2003;23:748-755
 
4) Sodium, R et al:Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 2001;38:1942-1949
 
5) 丸山幸夫ほか:急性心不全治療ガイドライン(2006年改訂版), 循環器病の診断と治療に関するガイドライン(2004-2005年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2006_maruyama_h.pdf(2011年8月閲覧)
 
6) 松崎益徳ほか:慢性心不全治療ガイドライン(2010年改訂版), 循環器病の診断と治療に関するガイドライン(2009年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf(2011年8月閲覧)
 
7) Oz, MC et al:Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 1995;92(suppl):II169-II173
 
8) Rose, EA et al:Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure(REMATCH)Study Group:Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-1443
 
9) Slaughter, MS et al:HeartMate II Investigators:Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251
 
10) 許 俊鋭:重症心不全患者の在宅治療の展望. Clinical Engineering 2010;21:539-545
 
11) Wieselthaler, GM et al:HVAD Clinical Investigators:Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010;29:1218-1225
 
P.364 掲載の参考文献
1) Kirklin, JK et al:Third INTERMACS annual report:the evolution of destination therapy in the United States. J Heart Lung Transplant 2011;30:115-123
 
2) Hunt, SA et al:American College of Cardiology Foundation;American Heart Association. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults:A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-e90
 
3) Stevenson, LW:Clinical use of inotropic therapy for heart failure:looking backward or forward? Part I:inotropic infusions during hospitalization. Circulation 2003;108:367-372
 
4) Stevenson, LW:Clinical use of inotropic therapy for heart failure:looking backward or forward? Part II:chronic inotropic therapy. Circulation 2003;108:492-497
 
5) Westaby, S et al:Destination therapy with a rotary blood pump and novel power delivery. Eur J Cardiothorac Surg 2010;37:350-356
 
6) 山嵜健二ほか:次世代型補助人工心臓EVAHEARTの臨床治験. 移植2009;44:603-603
 
7) Slaughter, MS et al:Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251
 
8) Morshuis, M et al:European experience of Dura-HeartTM magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg 2009;35:1020-1028
 
P.369 掲載の参考文献
1) Fricker, FJ et al:Heart transplantation in children:Indications. Pediatr Transplant 1999;3:333-342
 
2) Denfield, SW:Sudden death in children with restrictive cardiomyopathy. Card Electrophysiol Rev 2002;6:163-167
 
3) Jenkins, PC et al:Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome. J Am Coll Cardiol 2000;36:1178-1185
 
4) Carey, JA et al:Orthotopic cardiac transplantation for the failing Fontan circulation. Eur J Cardio-Thorac Surg 1998;14:7-14
PubMed
5) 西川俊郎ほか:小児期心筋症の全国調査, 追跡調査結果. 日小児循環器会誌 2005;21:55-58
 
6) Chen, S et al:Clinical spectrum of restrictive cardiomyopathy in children. J Heart Lung Transplant 2001;20:90-92
 
P.373 掲載の参考文献
1) Barnard, CN:The operation. A human cardiac transplant:an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967;41:1271-1274
 
2) ISHLT:The International Society for Heart and Lung Transplantation http://www.ishlt.org/
 
3) Hori, M et al:Successful launch of cardiac transplantation in Japan. Jpn Circ J 2000;64:326-332
 
4) 日本循環器学会心臓移植委員会ホームページ http://www.j-circ.or.jp/index.htm
 
5) Di Salvo, TG et al:Mitral Valve Surgery in Advanced Heart Failure. J Am Coll Cardiol 2010;55:271-282, Review
PubMed
6) Mehra, MR et al:Listing Criteria for Heart Transplantation:International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates-2006. J Heart Lung Transplant 2006;25:1024
PubMed
7) 日本臓器移植ネットワーク http://www.jotnw.or.jp/
 
8) Muller, J et al:Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96:542-549
 
P.377 掲載の参考文献
1) Martin, J et al:Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 2004;25:971-977
 
2) Mehra, MR et al:Listing criteria for heart transplantation:International society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006;25:1035-1042
 
3) Hunt, SA et al:2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-e479
 
P.379 掲載の参考文献
1) Chung, ES et al:Results of the Predictors of Response to CRT(PROSPECT)Trial. Circulation 2008;117:2608-2616
 
2) Lindenfeld, J et al:Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association Class IV heart failure. Circulation 2007;115;204-212
 
3) Diaz-Infante, E et al:Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436-1440
 
4) Daubert, C et al:Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction. J Am Coll Cardiol 2009;54:1837-1846
PubMed
5) Moss, AJ et al:Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338
 
P.381 掲載の参考文献
1) Rose, EA et al:Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-1443
 
2) Slaughter, MS et al:Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251
 
3) Crow, S et al:Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010;90:1263-1269
 
P.387 掲載の参考文献
1) Ling, LH et al:Constrictive pericarditis in the modern era. Evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation 1999;100:1380-1386
 
2) Oh, JK et al:The Echo Manual, 3rd ed, Lippincott Williams & Wilkins, Philadelphia, 2006
 
3) Haley, JH et al:Transient constrictive pericarditis:causes and natural history. J Am Coll Cardiol 2004;43:271-275
 
4) Ha, JW et al:Impact of left ventricular function on immediate and long-term outcomes after pericardiectomy in constrictive pericarditis. J Thorac Cardiovasc Surg 2008;136:1136-1141
 
5) Senni, M et al:Left ventricular systolic and diastolic function after pericardiectomy in patients with constrictive pericarditis. Doppler echocardiographic findings and correlation with clinical status. J Am Coll Cardiol 1999;33:1182-1188
 
6) Bertog, SC et al:Constrictive pericarditis:etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 2004;43:1445-1452
 
P.392 掲載の参考文献
1) Schwefer, M et al:Constrictive pericarditis, still a diagnostic challenge:comprehensive review of clinical management. Eur J Cardiothorac Surg 2009;36:502-510
 
2) The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary. Eur Heart J 2004;25:587-610
 
3) Khandaker, MH et al:Pericardial disease:Diagnosis and management. Mayo Clin Proc 2010;85:572-593
 
4) Ueda, Y et al:Thoracic and cardiovascular surgery in Japan during 2007. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2009;57:488-513
 
5) Sakata, R et al:Thoracic and cardiovascular surgery in Japan during 2008. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2010;58:356-383
 
6) Ling, LH et al:Constrictive pericarditis in the modern era:evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation 1999;100:1380-1386
 
7) Bertog, SC et al:Constrictive pericarditis:etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 2004;43:1445-1452
 
8) Matsuyama, K et al:Clinical characteristics of patients with constrictive pericarditis after coronary bypass surgery. Jpn Circ J 2001;65:480-482
 
9) Jaume, SS et al:Effusive-constrictive pericarditis. N Engl J Med 2004;350:469-475
 
10) Kouchoukos, NT et al:Pericardial Disease in Cardiac Surgery, 3rd ed, Churchill Livingstone, Philadelphia, 2003, 1779-1795
 
11) Heimbecker, RO et al:Surgical technique for the management of constrictive epicarditis complicating constrictive pericarditis(the waffle procedure). Ann Thorac Surg 1983;36:605-606
 
P.396 掲載の参考文献
1) Wyse, DG et al:A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833
 
2) Van Gelder, IC et al:A comparison of rate control and rhythm control in patients with recurrent atrial fibrillation. N Engl J Med 2002;347:1834-1840
 
3) Ogawa, S et al:Optimal treatment strategy for patients with paroxysmal atrial fibrillation:J-RHYTHM Study. Circ J 2009;73:242-248
 
4) Haissaguerre, M et al:Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666
 
5) Noheria, A et al:Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation:a systematic review. Arch Intern Med 2008;168:581-586
 
6) Ouyang, F et al:Long term results of catheter ablation in paroxysmal atrial fibrillation;Lessons from 5 year follow-up. Circulation 2010;122:2368-2377
 
7) 小川 聡ほか:心房細動治療(薬物)ガイドライン(2008年改訂版), 循環器病の診断と治療に関するガイドライン(2006-2007年度合同研究班報告). Circ J 2008;72(suppl IV):1581-1638
 
8) Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-2429
 
9) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline):A report of the ACCF/AHA Task Force on Practical Guidelines. Circulation 2011;123:104-123
PubMed
P.400 掲載の参考文献
1) Wolf, RK et al:Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg 2005;130:797-802
 
2) Beyer, E et al:Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation:early multicenter results. J Thorac Cardiovasc Surg 2009;137:521-526
 
3) Cui, YQ et al:Video-assisted minimally invasive surgery for lone atrial fibrillation:a clinical report of 81 cases. J Thorac Cardiovasc Surg 2010;139:326-332
 
4) Edgerton, JR et al:Minimally invasive surgical ablation of atrial fibrillation:six-month results. J Thorac Cardiovasc Surg 2009;138:109-113
 
5) Fujita, T et al:Long-term outcome of combined valve repair and maze procedure for nonrheumatic mitral regurgitation. J Thorac Cardiovasc Surg 2010;140:1332-1337